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ABSTRACT 
Aim 
This study set out to evaluate the clinical and aesthetic outcomes of connective tissue grafts 
(CTG) to platelet rich fibrin (PRF) in treating gingival recession. It was hypothesised that PRF 
could be as effective as CTGs in treating recession with improved aesthetic results. To the 
best of my knowledge this clinical study is unique in the South African setting in that an 
objective aesthetic scoring system was used to report on aesthetic changes and also this 
study was patient based to determine patient satisfaction with aesthetic outcomes.   
Methods and materials 
This six month study was an extended case series with a randomised split-mouth design. Six 
patients with a total of twenty two sites underwent treatment. However, only five patients 
fulfiled the study’s follow-up requirements. The patient who failed to comply with the 
follow-up appointments was disqualified from the study. Each site was paired with a similar 
lesion on the opposite or contralateral side and randomly assigned to the CTG (control) or 
PRF (test) treatment. Six variables were recorded over the study period. These variables 
were probing depth, recession depth, recession width, clinical attachment level, keratinised 
tissue width and gingival thickness. These were measured at the following intervals: 0, 8, 12, 
16 and 24 weeks. Photographs were taken at baseline and at 24 weeks to evaluate 
aesthetics using the Pink Esthetic Score. At the end of the study period, patients were given 
a questionnaire to assess their satisfaction with treatment outcomes.  
Results and Conclusions 
Both treatments improved the clinical outcomes but CTGs demonstrated improvements at a 
greater number of sites than PRF (60% to 30% respectively). The aesthetic scores improved 
at four sites for both CTGs and PRF with only one site in each group scoring lower at the end 
of the study. The aesthetic scores at the remaining sites did not change over the study 
period. Therefore, both CTGs and PRF demonstrated the potential to improve or maintain 
aesthetic results. Analyses of the patient questionnaire showed that patients were satisfied 
with the aesthetic outcomes of both treatments.  
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The results from this study indicate that both CTGs and PRF membranes can be effective in 
treating gingival recession and both treatments can improve clinical and aesthetic 
outcomes.
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CHAPTER 1 
1 Introduction 
Gingival recession is a common dental complaint and is defined as “an apical movement of 
the gingival margin to below the cemento-enamel junction (CEJ) thus exposing the root 
surface”.1-5   
Gingival recession may cause dentine hypersensitivity, root caries, decreased plaque control 
motivation and poor aesthetics.6, 7 Treatment options range from the conservative and 
minimally invasive such as monitoring and preventative management of aetiological factors 
to dentine sealants and various types of restorations to the more comprehensive approach 
of periodontal plastic surgery.6, 7 
Gingival recessions can lead to multiple and diverse consequences. Therefore, determining 
the degree of success of any chosen treatment is multifaceted. The selected treatment 
needs to improve the gingival architecture namely: the contours of the gingival margin and 
interdental papilla, gingival thickness and width in order to improve periodontal health, 
reduce dentine hypersensitivity and satisfy the patient’s aesthetic concerns. 
Traditionally, a connective tissue graft (CTG) in combination with a coronally advanced flap 
(CAF) is considered the surgical gold standard to treat gingival recession.8-16 This study aims 
to compare this gold standard with a newer technique; a platelet-rich fibrin (PRF) 
membrane with a modified CAF.  
PRF is a wholly autogenous biomaterial.17 It is simple, quick and relatively inexpensive to 
prepare. It is made up of a 3-dimensional fibrin matrix that is rich in platelets, leukocytes 
and growth factors.17, 18 Each component of the PRF biomaterial contributes factors that can 
enhance wound healing and tissue regeneration.19  
Systematic reviews have highlighted a paucity of information with regards to patient-based 
outcomes and aesthetics in the literature.8, 20 Together with clinical outcomes, Cortellini and 
Pini-Prato eloquently state that the true goal of any treatment should be ‘patient 
satisfaction’.20 This study aims to compare the clinical and aesthetic outcomes of CTGs and 
PRF in treating gingival recessions. This study will also report on patient satisfaction 
between the two groups.          
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CHAPTER 2 
2 Literature review  
2.1 Gingival Recession 
In 1967, Gorman discussed the prevalence and aetiology of gingival recession. He defined 
gingival recession as exposure of a tooth’s root surface as a result of apical migration of the 
gingiva.5 Over a decade later, in 1979 Maynard and Wilson proposed a review of the 
nomenclature to update both the term gingival recession and its definition. They suggested 
the term “marginal tissue recession” and defined it as exposure of the root surface by apical 
migration of the soft tissue margin.4 This term was widely accepted because the soft tissue 
margin may not always be composed of gingiva; in some instances, it may comprise of 
alveolar mucosa only.4 Today, these terms are used interchangeably and “marginal tissue 
recession” is referred to as “gingival recession” in this paper.   
Gingival recessions are a common dental problem and usually found during routine dental 
examinations or the symptoms caused by gingival recessions prompt patients to seek 
treatment.  
Many epidemiological studies have shown that its prevalence varies between groups 
ranging from 11% to 100%.6, 7, 21-24 Recession lesions are just as likely to present in patients 
with good periodontal health and good oral hygiene habits as in patients with periodontitis 
or gingivitis and poor oral hygiene.3, 6  Gingival recession can present as isolated lesions on a 
single tooth or be widespread and include multiple teeth.3   
 Aetiology 
Gingival recession is most likely the result of an inflammatory process that may be triggered 
by a variety of factors.22 The literature is replete with ambiguity with regards to the terms 
‘cause/aetiology/pre-disposing factors and risk factors’. Many authors have classified and 
grouped these factors in various different ways. Tugnait and Clerehugh classified 
aetiological factors as related to either pathological or non-pathological alveolar bone loss.6 
Marini et al. on the other hand classified the aetiological factors according to predisposing 
or precipitating factors.22 Patel et al. then classified aetiological factors as either a direct 
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result of mechanical or physical insult to the gingival tissues or as an indirect response to an 
inflammatory reaction in the gingival tissues.7  
For the purpose of clarity of these terms, I will be referring to Lang and Lindhe, who 
categorised the aetiology of gingival recession into three main groups:25 
1. Gingival recession associated with mechanical trauma.  
2. Gingival recession associated with localised plaque-induced inflammatory lesions. 
3. Gingival recessions associated with generalised types of destructive periodontal 
disease. 
2.1.1.1 Mechanical Trauma 
The mechanical trauma most commonly associated with gingival recession is aggressive oral 
hygiene habits.3, 25 These types of lesions are usually found in patients with good plaque 
control and healthy gingiva.21 Aggressive oral hygiene habits include aggressive brushing 
force and technique, increased tooth brushing frequency, increased brushing time, firmness 
of toothbrush bristles and using old and damaged toothbrushes.3, 26, 27  
However, not all patients with aggressive oral hygiene habits will present with gingival 
recession. Anatomical factors such as a thin gingival biotype, a thinner alveolar osseous 
plate and a tooth in a more buccal or lingual position on the arch increase the risk of gingival 
recessions developing in a particular area or patient.3, 6, 28 Thick gingival biotypes and its 
associated positive anatomical factors are thought to be more resistant to inflammation and 
trauma.28, 29    
2.1.1.2 Localised Plaque-induced Inflammatory Lesions 
These types of lesions develop in response to the presence of subgingival bacterial plaque. 
Plaque accumulation can induce localised areas of inflammation. In areas of anatomical 
vulnerability, this inflammatory response can cause localised destruction of the gingival 
tissues resulting in apical movement of the gingival margin.3  
2.1.1.3 Generalised Destructive Periodontitis 
Subgingival periodontal pathogens elicit a host inflammatory response that destroys 
alveolar bone and soft tissue attachment.3, 6, 7  This tissue destruction can extend into the 
interproximal area inducing compensatory remodeling of the periodontal tissues resulting in 
apical migration of the gingival margin.25  
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 Predisposing Factors 
There are many predisposing factors that may lead to the development of gingival 
recession. Zuchelli and Mounssif divided these risk factors into three categories.3 
1. Anatomical factors. 
2. Physiological factors. 
3. Pathological factors. 
2.1.2.1 Anatomical Factors:  
 Fenestrations or dehiscences of alveolar bone:                                                                  
A dehiscence is “a defect in which the alveolar crest of buccal bone is at least 4mm 
apical to the crest of interproximal bone”.30 
A fenestration is “a localised defect of the buccal, lingual or palatal alveolar plate 
which exposes the root surface but does not involve the alveolar margin”.30 
These types of bone defects can cause loss of the overlying soft tissue thus 
increasing the risk of gingival recession.6, 7, 22 
 Atypical eruption pathway / abnormal tooth position in the arch:  
When a tooth follows an atypical eruption pathway, the tooth can be placed in a 
more buccal position.3, 6  This placement causes the cervical portion of the root to be 
placed in crestal bone resulting in a thinner than usual buccal plate thereby 
increasing susceptibility to bone resorption.3  
 Root morphology:  
There are two important aspects of root morphology that increase susceptibility to a 
tooth developing gingival recession. Teeth with long and narrow roots are more 
susceptible to these defects than teeth with short, broad roots. Also, teeth with 
roots that are equal in thickness to the thickness of the crestal bone are at an 
increased risk to developing gingival recessions.3 
 Prominent frenal and muscle attachments:  
Prominent and/or additional frenal and muscle attachments are associated with 
localised gingival recession lesions.6, 22, 24 The increased tension from these atypical 
attachments can cause direct pull on the marginal gingiva prompting apical 
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migration of the gingiva resulting in gingival recession. It can also hinder efficient 
plaque control from the discomfort whilst brushing, triggering localised areas of 
inflammation and subsequent gingival recession.6  
 Shallow vestibule: 
Generally, a shallow vestibule implies an inadequate width of keratinised gingiva.31 
However, there has been much debate as to what is considered an optimum width 
of keratinised gingiva. Lang and Lӧe suggested that 2mm of keratinised gingiva is the 
required minimum to maintain periodontal health.32 This theory has been challenged 
and it was found that periodontal health can be maintained in the absence of 
keratinised tissue.33, 34  
However, studies around peri-implant tissues have shown that insufficient 
keratinised tissue width is associated with higher plaque accumulation, gingival 
inflammation, bleeding on probing, and gingival recession.35 Berglundh et al. 
conducted a study on beagle dogs to determine the effects of new plaque formation 
on gingiva around implants and teeth.36 They found that gingiva around implants and 
natural teeth have the same potential to develop inflammation to plaque 
formation.36 Pontoreiro et al. conducted a similar study in humans where gingival 
inflammation was experimentally induced around teeth and implants by withholding 
plaque control measures.37 After three weeks, clinical examinations were done at all 
sites to determine the inflammatory response. There was no statistically significant 
difference found in tissue response between teeth and implant sites.37   
Therefore studies carried out on implants have a basis on natural teeth and it can be 
reasoned that insufficient keratinised tissue width around teeth is also associated 
with higher plaque accumulation, gingival inflammation, bleeding on probing, and 
gingival recession.36, 37   
2.1.2.2 Physiological Factors:  
 Thin gingival biotype:  
Thin, delicate gingival tissue is less resistant to microbial induced inflammation or 
traumatic insult whereas thick gingival biotypes are more resistant to chemical 
and mechanical insults such as inflammation, toothbrush abrasion, the packing of 
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impression cords into the gingival sulcus and poor restorative margins.3, 6, 25, 28 
Hence, thin gingival biotypes are predisposed to gingival recession.7, 22  
 Teeth that are positioned outside of the buccal plate:  
Atypical eruption pathways or orthodontic tooth movement which retains teeth 
in a position outside of the buccal bone increases the risk of bone loss and 
subsequent soft tissue loss.3, 6, 38  
2.1.2.3 Pathological Factors: 3 
 Physical trauma:  
Trauma to the periodontal tissues can be caused by abrasive oral hygiene 
techniques, traumatic occlusion, perioral and intraoral piercings or self-inflicted 
trauma as a result of aberrant habits such as nail-biting, toothpick use, etc.3, 6, 22, 38  
 Chemical trauma: 
Smokers tend to exhibit increased frequency of gingival recession than non-
smokers.6 Chronic topical application of drugs or smokeless tobacco also increases 
the risk of gingival recessions developing in the area adjacent to where the tobacco 
is placed, usually the mandibular labial and buccal vestibule.6, 39 
 Iatrogenic damage:  
Iatrogenic damage as a result of subgingival restorations or poorly designed partial 
dentures increases the risk of gingival recessions developing in these areas.3 6, 7   
 Sequelae 
Gingival recession can cause a range of symptoms including dentine hypersensitivity, 
enamel abrasion, root caries, loss of keratinised tissue width, plaque retention with gingival 
bleeding and poor aesthetics in patients with high smile lines.3, 6, 7, 13  
2.1.3.1 Dentine Hypersensitivity 
Dentine hypersensitivity can be twofold; thermal and/or tactile. Thermal hypersensitivity is 
common on cold stimuli and causes sharp intense pain of short duration at the affected 
areas.6 Tactile hypersensitivity can be determined clinically by merely running a diagnostic 
probe along the cervical dentine. Patients feel pain at this metallic touch. This type of 
hypersensitivity can make brushing uncomfortable or painful and therefore difficult for 
patients to effectively manage plaque control in the affected areas. This can perpetuate the 
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recession lesions as there will be increased plaque accumulation, eliciting an inflammatory 
response and possibly worsening the extent of the recession lesion.  
The hydrodynamic theory of pain is the most commonly accepted theory to explain dentine 
hypersensitivity.6 Stimuli on the cervical dentine causes movement of dentinal fluid within 
the dentine tubules. This, in turn, activates the sensory nerve fibres in the dentine and at 
the dentino-pulpal junction, eliciting a pain response.6 However, pain is perceptive and not 
all patients experience pain at exposed root surfaces. In those who do experience pain, the 
intensity of pain varies from a slight sensitivity to a sharp and intense pain.  
2.1.3.2 Cervical Tooth Abrasion 
These dental defects are typically non-carious, wedge-shaped and appear at the cervical 
area of teeth.40 These defects are usually caused by mechanical trauma typical of aggressive 
tooth brushing techniques. Aggressive tooth brushing can also cause trauma to the gingival 
soft tissues inducing gingival recessions to develop. With continued trauma after apical 
movement of the gingival margin, abrasion of the cervical enamel, dentine or cementum 
may occur.3  
2.1.3.3 Root Caries 
All tooth surfaces that are exposed to the oral environment are susceptible to decay. 
Gingival recession exposes root surfaces that were previously protected by the gingiva. 
Once the cementum on these exposed root surfaces are destroyed, pain may be felt in 
these areas compromising effective plaque control leading to the development of root 
caries.3, 6 
2.1.3.4 Loss of Keratinised tissue Width  
Keratinised tissue is firmly attached to the underlying bone and is well suited to withstand 
masticatory forces and resist injury from physical, thermal and chemical stimuli of everyday 
exposures.41  With gingival recession, keratinised tissue is reduced or lost and the overall 
width of this tissue decreases. This, in turn, can cause the vestibule to narrow and can make 
brushing uncomfortable and painful impeding effective plaque control. Insufficient 
keratinised tissue width is associated with higher plaque accumulation, gingival 
inflammation, bleeding on probing, and gingival recession.22, 35  
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2.1.3.5 Plaque Retention and Gingival Bleeding 
The combined effects of dentine hypersensitivity, reduced keratinised tissue width and a 
shallower vestibule can cause difficulty in maintaining effective plaque control. Plaque 
accumulation increases the inflammatory response causing gingival bleeding and 
subsequently worsening the recession lesions in a vicious cycle complex.3  
2.1.3.6 Poor Aesthetics 
The principles of smile design include aesthetic and functional components to create a 
harmonious integration between the two. Gingival recession affects the dental component 
of an ideal smile. The dental component relates specifically to teeth and their relationship to 
the gingival tissues.42  The gingival perspective of aesthetics is the most quantifiable, and 
least prone to subjective interpretation.43 The gingiva is the frame of the teeth and any 
change to the ideal level or shape of the gingival margin may disrupt the ideal proportions 
of the mucogingival complex compromising aesthetics.42  
Apical movement of the gingival margin increases the clinical crown length of a tooth.44 
When this phenomena occurs in the anterior zone, this disharmony may be apparent in the 
patient’s smile or even at a functional level affecting phonetics.44 The exposed roots also 
tend to be darker and more yellow than enamel worsening overall aesthetics.6  Gingival 
recession lesions can also cause loss of symmetry of the natural gingival scalloping resulting 
in disharmony of the gingival margin.3, 6 A discerning patient with a high smile line often 
influences the “aesthetic zone”. These patients usually have high expectations for treatment 
outcomes. Furthermore, the current age of “Extreme Makeovers” and instant fixes have 
made patients more aesthetic conscious and subsequently patient aesthetic expectations 
are higher than in the past. The aim of any treatment should be to restore the gingival 
architecture and holistically improve aesthetics and function. 
 Management 
Gingival recession treatments include monitoring and preventative management of 
aetiological factors and treating symptoms with dentine sealants, restorations and 
periodontal plastic surgery.6, 7  
Conservative preventative measures such as dentine sealants can reduce dentine 
hypersensitivity but does not restore and improve aesthetics. Class V restorations, crowns 
 9 
 
and veneers elongate the clinical crown length and may worsen aesthetics by creating 
disproportionately long teeth and can result in a disharmonious smile.6 Periodontal plastic 
surgery is able to restore the gingival tissue architecture and holistically improve aesthetics. 
Periodontal plastic surgery is a term that encompasses a range of surgical techniques which 
aim to recreate and restore the gingival anatomy and morphology. Surgical treatments to 
restore gingival recessions fall under the umbrella of periodontal plastic surgery. 
Gingival recessions can lead to multiple and diverse consequences, therefore determining 
the degree of success of treatment can be multifaceted. The chosen treatment has to 
restore gingival architecture thereby improving periodontal health in order to maintain oral 
health. In addition, treatment has to satisfy both the clinician’s and the patient’s aesthetic 
concerns. 
  Recession Classification System 
In 1968, Sullivan and Atkins classified gingival recession into four groups: 1) Shallow-narrow.                
2) Shallow-wide. 3) Deep-narrow. 4) Deep-wide.45 This classification system is useful in 
categorising recession lesions but is limited in predicting prognosis of surgical treatment.1 A 
more useful classification system was created by PD Miller in 1985.46  
Miller’s classification system aids in the diagnosis and prognosis of predictable outcomes of 
surgical treatments.25, 46-48  Miller used the presence or absence of the interdental papilla as 
one of the key elements in his classification system, as the papilla level is the most 
significant prognostic factor for root coverage.46 In lesions with interdental papilla loss, the 
aesthetic outcome is compromised as only partial root coverage is predicted. In this study, 
Miller’s recession classification system was used to determine the severity of the recession 
lesions. There are four classes in this classification system.  
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1. Miller’s Class I  
 
Figure 2.1: Miller’s class I. 
Gingival recession that does not extend beyond the MGJ without periodontal tissue loss in 
the interdental area. 100% root coverage is possible.46                                                        
2. Miller’s Class II  
 
Figure 2.2: Miller’s class II. 
Gingival recession that extends to or beyond the MGJ without periodontal tissue loss in the 
interdental area. 100% root coverage is possible.46    
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3. Miller’s Class III                                                                                                                                                                          
 
Figure 2.3: Miller’s class III. 
Gingival recession that extends to or beyond the MGJ with periodontal tissue loss in the 
interdental area or malpositioning of teeth.46 The interdental tissue loss is coronal to the 
apical extent of the gingival margin. These features prevent 100% root coverage and only 
partial root coverage can be expected.46 
4. Miller’s Class IV  
 
Figure 2.4: Miller’s class IV. 
Gingival recession that extends to or beyond the MGJ with periodontal tissue loss in the 
interdental area and/or malpositioning of teeth.46 The interdental tissue loss extends to a 
level apical to the gingival margin. Root coverage cannot be expected in class IV lesions.46    
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2.2 The Mucogingival Complex and Gingival Biotype  
 
Figure 2.5: Mucogingival complex.49 
 
 Clinical Features 
The gingiva is that part of the oral mucosa which covers the alveolar process and surrounds 
the neck of the teeth. The free gingival margin is the coronal limit of the gingiva and the 
apical limit is continuous with the alveolar mucosa.50  The border between the gingiva and 
alveolar mucosa is usually distinct and called the mucogingival junction (MGJ). The gingiva 
can be divided anatomically into marginal (free), attached and interdental gingiva.41 After 
tooth eruption, in health the free gingival margin is located on the enamel surface 
approximately 0.5 – 2mm coronal to the CEJ.41 The free gingiva extends from the gingival 
margin in an apical direction to the free gingival groove creating what is known as the 
gingival sulcus (see figure 2.6). The soft tissue which is attached to the tooth coronal to the 
alveolar crest is regarded as the biological width (see figure 2.7)  and is essential in 
maintaining periodontal health.51 The attached gingiva extends from the free gingival 
groove coronally to the MGJ apically and is firm, resilient and firmly attached to the 
underlying alveolar bone and cementum.50 These structural features allow the attached 
gingiva to meet its functional demands and withstand the shearing forces of mastication.52 
Attached gingiva is also referred to as keratinised mucosa and its width and thickness is 
genetically determined.41  
Free gingival margin 
Marginal gingiva 
Mucogingival junction  
Interdental gingiva/papilla 
Attached gingiva  
Alveolar mucosa  
Free gingival groove 
Keratinised 
gingiva 
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Figure 2.6: Cross-sectional view of the mucogingival complex53 
 
Figure 2.7: Diagrammatic representation of the biological width.54 
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 Histological Features  
 
Figure 2.8: Histological appearance of the oral mucosa.55  
Oral mucosa comprises of two distinct tissue components, the overlying epithelium and the 
underlying lamina propria (or connective tissue). These components are separated by a 
basement membrane and the oral mucosa is separated from the underlying bone or muscle 
by the submucosa.50   
Oral epithelium is stratified squamous epithelium and can be nonkeratinised,  keratinised, 
parakeratinised or a combination of keratinised and parakeratinised.50 The masticatory 
mucosa of the gingiva and hard palate is keratinised and better able to withstand the 
shearing forces of mastication while lining mucosa may be non-keratinised or 
parakeratinised depending on where it is positioned in the oral cavity. The majority of cells 
in the oral epithelium are keratinocytes (90% of the cell population) and the remainder are 
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nonkeratinocytes made up of melanocytes, Langerhans cells, Merkel’s cells and 
inflammatory cells.25, 50   
The connective tissue lies subjacent to the oral epithelium and consists of fibres, cells, blood 
vessels and nerves embedded in an amorphous ground substance. The border between the 
oral epithelium and the connective tissue has an undulating interface. The oral epithelium 
lacks a blood supply and so it is the epithelial-connective tissue junction which allows for 
metabolic exchange between these two structures.50 
The connective tissue has two layers:1 
1. A superficial papillary layer below the epithelium. This layer projects connective 
tissue papillae that interdigitate between epithelial rete pegs. This structural 
arrangement of the epithelial-connective tissue junction increases the surface area 
of the interface than if the junction were flat. It is thought that this arrangement 
provides improved attachment allowing forces applied to the epithelial surface to be 
dispersed over a greater area of connective tissue. 
2. A deeper reticular layer adjacent to the alveolar bone. Reticular refers to the net-like 
appearance of the collagen fibres. 
 
As with oral epithelium, the connective tissue also exhibits regional variation in the 
proportion of its constitutional elements. The connective tissue of masticatory mucosa is 
firm with fewer elastic fibres. The elastic fibres of masticatory mucosa are usually associated 
with blood vessels. The connective tissue of lining mucosa, on the other hand, has more 
elastic fibres making it stretchable and able to move with muscle movements. 
The oral epithelium is separated from the underlying connective tissue by a basement 
membrane composed of collagen, laminin, heparin sulphate proteoglycan and fibronectin.50 
The basement membrane maintains cellular organisation, acts as a filter to molecules 
between the epithelium and connective tissue and is a barrier to cellular migration. The 
basement membrane also provides the signaling essential for epithelial differentiation and 
the development and maintenance of epithelial cell polarity.50 
The submucosa separates the oral mucosa from the underlying bone or muscle.50 The 
submucosa is composed of loose fatty or glandular tissue, blood vessels, nerves and minor 
salivary glands. In the gingiva and parts of the hard palate, the oral mucosa is directly 
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attached to the periosteum of the underlying bone with no submucosa. This is known as 
mucoperiosteum and has a firm inelastic attachment.50 
2.3 The Significance of Keratinised Mucosa 
The major differences between keratinised and non-keratinised mucosa is in the structure 
and differentiation of the epithelium, the epithelial-connective tissue interface and the 
density and elasticity of the connective tissue fibres.56 These differences allow keratinised 
mucosa to be tougher and better equipped to withstand the shearing forces mastication 
and to dissipate the pull of the alveolar musculature.57  
Keratinised tissue width varies from between 1-9mm.32 In 1972, Lang and Lӧe found that a 
keratinised tissue width of at least 2mm (1mm of free gingiva and 1mm of attached gingiva) 
was adequate to maintain gingival health.32 As discussed previously, this theory has been 
challenged and it was found that periodontal health can be maintained even in the absence 
of keratinised tissue.33, 34  
Berglundh et al. conducted a study on beagle dogs to determine the effects of new plaque 
formation on the gingiva around implants when compared to teeth.36 They found that the 
gingiva around implants and natural teeth have the same potential to develop inflammation 
in response to plaque formation.36 Pontoreiro et al. conducted a similar study in humans 
where gingival inflammation was experimentally induced around teeth and implants by 
withholding plaque control measures.37 After three weeks, clinical and histological 
examinations were done at all sites to determine the inflammatory response. There was no 
statistically significant difference found in the tissue response between teeth and implant 
sites.37 In 2008, Bouri et al. studied the relationship between keratinised tissue width and 
gingival health around implants. They concluded that 2mm of attached gingiva maintains 
peri-implant health.58  These studies demonstrate that an insufficient width of keratinised 
tissue around implants is associated with higher plaque accumulation, gingival 
inflammation, bleeding on probing, and gingival recession.35-37, 58 Studies carried out on 
implants have a basis on natural teeth and it can be reasoned that insufficient keratinised 
tissue width around teeth is also associated with higher plaque accumulation, gingival 
inflammation, bleeding on probing, and gingival recession.36, 37   
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In addition, thick keratinised gingival tissue serves as an effective barrier which is resistant 
to damage from the physical forces of mastication as well as thermal and chemical insults.41 
However, the point at which gingiva is determined as thick or thin is subjective.59, 60 Some 
authors state that gingival tissue which is ≤1.0 mm is thin and when it is ≥1.0 mm it is 
thick.60, 61 While others define thin gingiva as ≤1.5mm and thick gingiva ≥2.0mm.29 Yet other 
authors state that if a periodontal probe can be seen through the gingiva when inserted into 
the sulcus, the gingiva is thin and if it cannot be seen it is thick.59, 62  
Despite lack of agreement on what is thick or thin gingiva, all authors agree that thicker 
gingiva is important for gingival health. A positive correlation was found between gingival 
thickness and keratinised tissue width.29, 63, 64 Thicker, wider gingiva implies a thick bony 
underlying morphology and is more resistant to traumatic and inflammatory insults.29 On 
the other hand, thin and narrow gingiva implies a thin bony underlying morphology which is 
more susceptible to traumatic and inflammatory insults and subsequent periodontitis and 
greater gingival recession compared to thick gingival biotypes.29, 59  
It is important to determine the gingival biotype in treatment planning as it is a key 
prognostic factor that determines the degree of success or failure of surgical treatment.59 
The importance of thick gingiva was reviewed by Hwang et al. The authors found a positive 
correlation with increased gingival thickness and root coverage.65 They found that for good 
mean and complete root coverage a critical threshold for gingival thickness is greater than 
1.1 mm. The thicker the gingival tissue, the easier it is to manipulate and maintain 
vascularity.65 
2.4 Evolution and History of Periodontal Plastic Surgery 
Periodontal plastic surgery is a collective term to describe “surgical procedures performed 
to prevent or correct anatomical, developmental, traumatic or plaque-induced defects of 
the gingiva, alveolar mucosa or bone”.3, 13, 66-68  
Periodontal plastic surgical concepts evolved from the original principles of mucogingival 
surgery. Mucogingival surgery began in the 1950’s and aimed “to correct or enhance the 
thickness or change the position of mucogingival tissues” and was primarily concerned with 
improving function and did not consider gingival aesthetics.66  
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In its early days, mucogingival surgical techniques aimed to treat problems of attached 
gingiva, alveolar mucosa and shallow vestibules.52 Over time, the objectives of mucogingival 
surgery expanded to involve procedures to correct alveolar ridge deformities, surgical 
exposure of unerupted teeth, to improve the contours, symmetry and colour of marginal 
tissues and correction of aesthetic defects around implants.67, 69 These techniques took 
aesthetic problems into account. This diversity of surgical procedures propelled PD Miller to 
coin a new term: ‘periodontal plastic surgery’.68 Periodontal plastic surgery is a more 
comprehensive and descriptive term to the techniques used today.67  
Surgical management of gingival recessions fall into this category. The aim of such surgery is 
to restore the gingival anatomy and achieve complete root coverage, to increase keratinised 
tissue width, improve aesthetics related to the adjacent gingiva, to achieve minimal probing 
depths after healing and prevent worsening of the lesion. 3, 70 
Surgical techniques to treat gingival recession include CAF’s, pedicle flaps, lateral sliding 
flaps, double papilla rotational flaps, free gingival grafts,  connective tissue grafts, guided 
tissue regeneration, allografts and xenografts.10, 70 The gold standard of treatment is the 
bilaminar technique of combining a CTG with a CAF.8-13  
2.5 Connective Tissue Grafts  
Many studies have shown that CTGs combined with a CAF to be superior to other surgical 
techniques.3, 13, 70 This technique was introduced by Langer and Langer in the 1980’s.71 In 
root coverage procedures, the avascular root surface presents a challenge for wound 
healing and tissue regeneration.72 The success and predictability of a CTG with a CAF is 
credited to the double blood supply at the recipient site which ensures survival of the 
graft.3, 71, 73 The overlying flap and the periosteal connective tissue bed below provides this 
dual blood supply.71 The blood supply from the recipient bed nourishes the base of the graft 
while the overlying flap ensures survival of the most coronal part of the graft which lies over 
the avascular root surface.3, 74 In addition, the overlying flap also masks the white scar tissue 
and corrugated texture of the underlying CTG.3 
CTGs with a CAF have demonstrated significant improvements in root coverage, clinical 
attachment gain, keratinised tissue gain with superior colour matching to adjacent tissues 
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and provides the most predictable results.3, 12, 75  It has been found that an increase in 
gingival tissue thickness improves long-term stability of the treated area over a ten year 
period.76 This improvement in tissue thickness is a direct result of the CTG. 
CTGs can be sourced from the hard palate, retromolar pad area or an edentulous space 
when available.77 The retromolar pad and edentulous areas are often not large enough to 
produce optimal graft thickness and length. Therefore, CTGs are usually sourced from the 
hard palate.   
 Biological mechanisms of Connective Tissue Grafts 
The success of CTGs can be explained by epithelial-mesenchymal cellular interactions. 
During embryogenesis, mutual inductive influences occur between epithelial and 
mesenchymal tissues.  Induction is defined as the ability of one cell type to determine 
differentiation of adjacent cells of a different type78 and it is the process that initiates 
differentiation50. 
Odontogenesis is an example of this type of epithelial-mesenchymal interaction. During 
tooth development a well- regulated, sequential and reciprocal sequence of inductive 
interactions between stomodeal ectoderm and ectomesenchymal tissues result in tooth 
development.78, 79  
Studies have shown that it is similar in post-natal life. The first wound healing studies were 
carried out on dermal tissues and later on oral mucosa. These studies determined that 
stratified squamous epithelium of skin and oral mucosa is maintained in structure and 
function  by epithelial-mesenchymal interactions.56 
More than fifty years ago several researchers found that when epithelium was transplanted 
into a tissue type that was different in structure and function, it retained its original 
specificity. These studies demonstrated that the varied characteristic features of epithelium 
are genetically determined rather than as a result of functional adaptation.80  
In 1971, Karring et al. verified this discovery.80 The authors set out to test whether tissue 
specificity is pre-determined by some intrinsic factor within tissues or whether tissue 
specificity is determined by functional adaptation. Monkeys were used to heterotopically 
transplant keratinised and non-keratinised oral mucosa to different areas of the oral cavity 
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and they found that the transposed tissues retained their original features.80 In addition, 
non-keratinised tissue that was placed in close proximity to teeth underwent a histological 
change and a narrow band of keratinised tissue developed in these areas. The authors 
deduced that the most likely origin of granulation tissue at these wound sites was from the 
periodontal ligament and that it was signals from this connective tissue that induced the 
epithelial cells of the transposed non-keratinised tissue to differentiate into keratinised 
epithelium. They concluded that tissue cell specificity is genetically pre-determined and that 
epithelial differentiation is also influenced by signals from the underlying connective tissue 
and basement membrane at the recipient site.80  
Later studies which set out to determine the role of connective tissue in epithelial 
differentiation in humans, validated these findings. In 1974, Edel undertook a study where 
epithelial free CTGs from the palate were transplanted into areas that had less than 2mm of 
gingival keratinised tissue width.57 The recipient sites were clinically examined over a six 
month period and the MGJ at one site was histologically examined at six months. The graft 
area appeared keratinised with an increase in keratinised tissue width. These results 
demonstrated that a significant increase in keratinised tissue can be achieved by palatal 
connective tissue alone.57 In a similarly designed clinical study, Edel and Faccini studied the 
histological changes in similarly transplanted sites.81 After six months, histological 
examination found that the newly formed epithelium was keratinised with a normal 
architecture.81  In another study, Karring et al. transplanted free CTGs (void of epithelium) 
from keratinised and non-keratinised sources into alveolar mucosa.82 The grafts were placed 
into connective tissue pouches that were created as close to the overlying epithelium as 
possible. The transplanted tissue was then removed and studied at varied time intervals 
between one and twelve months. The non-keratinised graft tissue served as the control and 
there was no change at these sites. At sites where connective tissue from gingival mucosa 
were transplanted into alveolar mucosa, the original non-keratinised epithelium that 
covered the transplanted gingival connective tissue developed into keratinised epithelium 
that was indistinguishable from the original gingival epithelium. The junction between the 
transplanted non-elastic gingival connective tissue and the elastic alveolar connective tissue 
was also distinct and supports the idea that it is the gingival connective tissue that induced 
histodifferentiation of the overlying epithelium.82  
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In 1980, Bernimoulin and Schroeder set out to study the different types of alterations in 
epithelial differentiation after transplanting palatal CTG into alveolar mucosa.56 Six months 
after transplantation, these sites were biopsied and examined. The authors looked at the 
type of epithelial differentiation, the epithelial-connective tissue interface, the density and 
elasticity of the connective tissue fibres and various cellular organelles. Three of the seven 
test sites demonstrated characteristics almost identical to the hard palate while the 
remaining four test sites were different from typical alveolar mucosa but only slightly 
resembled the hard palate. These results also suggest that inductive stimuli originates from 
the connective tissue and not only influences epithelial differentiation but also the 
architecture of epithelial-connective tissue interface. The study also suggests that the 
epithelial response to these stimuli may depend on the type of epithelial differentiation 
pattern that exists at the recipient site.56  
Later studies by Hill, Mackenzie and Binnie reiterates these findings.83-86 They stated that in 
addition to histodifferentiation, connective tissue also directly influences mitotic activity, 
proliferation and migration of the overlying epithelium.83-86 They also found that while 
connective tissue has directive influences on epithelial differentiation, the ability of the 
epithelium to respond to these influences is also critical.84 Epithelial and mesenchymal 
connective tissues have a close and dependent interactive relationship that maintains its 
structural and functional specificity.  
In clinical application, this means that it is the origin of the regenerating tissues which 
determines the success and predictability of mucogingival surgery. Signals from the 
connective tissue of keratinised mucosa will induce keratinised epithelium to develop.82 In a 
study by Eren and Atilla where they treated localised gingival defects, the control group was 
a CTG combined with a CAF.12 They found an increase in gingival thickness in the control 
group and explained this phenomenon by the type of connective tissue that was 
transplanted. The connective tissue was harvested from the palate and hence contained the 
signals that influenced the overlying epithelium to develop into keratinised tissue increasing 
tissue thickness.12 This is the type of tissue that surgeons want to “re-create” when treating 
gingival recessions. However, there are disadvantages and complications associated with 
CTGs.   
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 The “Dark Side” of Connective Tissue Grafts 
Sourcing donor tissue from the palate increases surgical time and postoperative morbidity.3, 
77 A second surgical site prolongs pain and discomfort to the patient with an increased risk 
of haemorrhage and infection.77 Other reported complications are delayed wound healing 
and bone necrosis with sloughing of the overlying tissues.77 Anatomical considerations such 
as the position of the palatine neurovascular bundle which is in close proximity to the donor 
area, increases the risk of paraesthesia or permanent anaesthesia at the donor site.12, 77 
There is also a limited amount of graft tissue available from the palate limiting the number 
of recessions that can be treated in one sitting.12, 77  This may necessitate multiple surgical 
procedures to correct multiple recession lesions in one patient.  
In addition, CTGs can produce a dense and bulky tissue contour which requires a second 
surgery to correct.12 A systematic review by Chambrone et al. reported the following 
adverse reactions associated with the palatal donor site: postsurgical oedema, pain and 
necrosis of the palatal flap during the initial healing phase.8 Patients are usually anxious to 
undergo surgery in general but more so when the palate is a surgical site.77 Eliminating the 
necessity of the palate as a donor site will not only reduce morbidity of this procedure but 
patients will be more willing to consent to treatment. 
Alternatives to CTGs are commercially available barrier membranes, allografts, xenogeneic 
collagen membranes and enamel matrix derivative. These membranes have demonstrated 
success at improving gingival recessions and aesthetics.3, 6, 10, 12, 77 However, using these 
membranes can be technique sensitive and complications have been documented. In cases 
where non-resorbable membranes are used, a second surgery is required to remove the 
membrane. Complications specific to these membranes are membrane exposure and 
contamination.3 Newly formed periodontal tissue may be damaged when these membranes 
are removed or absorbed.3 Also, these materials are regarded as foreign bodies by recipient 
tissues and can disrupt the natural healing process.87  Furthermore, these membranes are 
expensive and most South African patients cannot afford to pursue these treatment 
options. Allografts and xenogeneic grafts are associated with risk of disease transmission, 
tissue rejection and may raise ethical concerns.3, 77  Some patients may not be willing to use 
xenogeneic membranes for religious or personal reasons as they are commonly derived 
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from bovine or porcine sources. In sum, these alternative membranes are not an adequate 
substitute for CTGs. A more natural autogenous substitute is sought.  
A more economical and potentially viable alternative is platelet concentrates; a natural 
autologous material. 
2.6 Platelet Concentrates 
The use of fibrin adhesives is well documented and can be said to be the precursor to the 
platelet concentrate evolution.88 Fibrin adhesives were first used in surgery to amplify the 
natural fibrin polymerisation process during haemostasis. Fibrin adhesives act like  “glue”, 
sealing wound edges to promote healing.88 The first fibrin adhesives were derived from 
allogeneic sources but with the risk of disease transmission, autologous adhesive protocols 
were developed. These protocols were complex, time-consuming and expensive.19 
Simplifying these protocols led to the development of platelet concentrates. When it was 
discovered that the growth factors within these concentrates could be harnessed, its 
applications expanded to tissue regeneration.89 
Platelet concentrates have been used in surgery to augment healing for forty years.89 In 
recent years, there has been a shift to utilise platelet concentrates as an adjunct to 
periodontal surgery to promote periodontal tissue regeneration. Platelet concentrates are 
autogenous biomaterials obtained from the patients’ own blood. The preparation of platelet 
concentrates have improved and simplified over the years.  It is easy, convenient and 
economical to produce while eliminating the risk of foreign body reactions and disease 
transmission. 
Platelet concentrates have diverse medical applications from healing sports tendon injuries 
to plastic surgery to aesthetic skin treatments.89 Oral surgical applications include but are 
not limited to sinus floor elevation, extraction socket preservation and augmentation,  
intrabony and furcation defects, peri-implant defects, regenerative endodontic treatment, 
root end surgery and soft tissue augmentation.12, 18 
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 The Platelet Concentrate Evolution 
 Platelet-rich plasma (PRP) 
PRP was the first platelet concentrate and in its liquid form was originally used in 
transfusion medicine to treat haemorrhagic disorders such as thrombocytopenia and 
leukaemia and in the treatment of significant blood loss during surgery.88, 90 Whole blood 
was separated to harvest platelets for transfusion. Thereafter, thrombin and calcium were 
added to PRP and it evolved into a fibrin concentrate. These preparations are similar to 
currently available fibrin adhesives and were used to control haemostasis.19 
PRP, as we know it today, was first discussed in the literature in the 1970’s for its wound 
healing properties. It was produced from platelet poor plasma and its production protocols 
were expensive, time-consuming and complex and thus its use failed to gain widespread 
popularity. Then, in the late 1990’s, a revolution occurred when high concentrations of 
growth factors were discovered in PRP preparations. In 1997, Whitman introduced PRP into 
the field of oral surgery as an adjunct to post-surgical healing.89 This compelled a surge in 
different production protocols to make it easier to produce PRP and in 1999, Anitua 
introduced a variation of PRP called Platelet Rich in Growth Factors.91  
Typical PRP preparations undergo a double centrifugation process with chemical additives 
to create a biomaterial rich in growth factors and cytokines. It was the idea of a growth 
factor enriched material that prompted its initial popularity.  
PRP preparation is a three-step process. It requires a double centrifugation cycle. The first 
cycle uses an anticoagulant and separates the platelets, the second cycle concentrates the 
platelets. This preparation is in a liquid form and PRP can be used as such and injected into 
the desired tissue but it is more commonly converted into a gel for topical application.89 
Bovine thrombin and/or calcium chloride or equivalent additives are added to the liquid PRP 
to initiate platelet activation and fibrin polymerisation inducing rapid gelling of the platelet 
concentrate.88, 90 This gellification ensures the slow release of growth factors and cytokines 
trapped within the preparation.88  
Kawase  et al. summarised the benefits of PRP as increasing cell proliferation and 
upregulates extracellular matrix production thereby promoting wound healing.92 Pradeep et 
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al. surmised that the fibrinogen in PRP reacts with thrombin thereby inducing clot 
formation.93 The fibrin clot then upregulates collagen synthesis in the extracellular matrix 
providing a scaffold for cellular migration and adhesion.93  PRP may also allow initial 
stabilisation and revascularisation of surgical flaps and grafts.11  
However, clinical results were controversial and contradictory. Its preparation protocols 
were technique sensitive, time-consuming and expensive. There was also the risk of disease 
transmission from bovine sourced anticoagulants and immune reactions and so PRP slowly 
lost favour.11, 19, 92, 94 With PRP, the role of fibrin within the preparation was not considered 
a necessary element and ignored. We now understand that the fibrin content and in 
particular its structure and arrangement is critical to the effectiveness of a platelet 
concentrate.  
Dohan et al. postulated that it is the rapid polymerisation process of PRP that causes the 
initial rapid release of cytokines, limiting clinical effectiveness of PRP.88 The clinical 
limitations have also been attributed to the high thrombin concentrations within PRP. These 
high thrombin concentrations create thick fibrin polymer junctions resulting in a firm and 
inflexible structure. This type of structure seals biological tissues very well and can control 
haemostasis but is not conducive to cytokine entrapment and cellular migration or 
interactions.88 PRP is ultimately a low-density fibrin material enriched with growth factors 
and cytokines. 
Anitua et al. also developed a type of PRP called plasma rich in growth factors (PRGF).91 
PRGF is a poor leukocyte platelet concentrate with the intent to suppress the pro-
inflammatory effect.19 Its preparation protocol involves several steps with a final step 
adding calcium chloride creating an unstable PRGF gel that needs to be used immediately. 
This protocol is not easily reproducible and is therefore not widely used and reported on.90 
 Platelet-rich fibrin (PRF) 
PRF was developed by Joseph Choukroun in the early 2000’s. Choukroun’s PRF has a simpler 
preparation protocol than PRP and eliminates the need for additives. PRF is a second 
generation platelet concentrate whose purpose is to “activate and facilitate healing and the 
regenerative capacity of the host tissue, by providing a strong fibrin scaffold, major growth 
factors and allowing space for tissue regeneration”.87 PRF is a fibrin clot enriched with 
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platelets, B- and T- lymphocytes, monocytes, stem cells, neutrophilic granulocytes and 
growth factors.19 
When compared to PRP, PRF is a biomaterial with a high-density fibrin network. This gel-like 
fibrin network is created by a slow and almost natural polymerisation process. This allows 
the slow release of the growth factors and cytokines within the fibrin.15  The fibrin network 
also acts as a scaffold for cellular migration and proliferation.  
PRF is prepared from the patient’s own blood and its preparation protocol is simple, 
efficient and relatively inexpensive. There are no anticoagulants or chemical additives added 
and involves only a single centrifugation step. This makes PRF wholly autogenous with an 
almost natural polymerisation process.88 Choukroun et al. defines PRF as a healing 
biomaterial.17 
 Concentrated growth factors 
In 2006, Sacco developed another type of PRF concentrate called concentrated growth 
factors (CGF).95 CGF is also an autogenous fibrin biomaterial. Its preparation protocol differs 
from Choukroun’s PRF in that it uses variable centrifugation speeds (Choukroun uses 
constant speeds) and produces a larger, denser fibrin matrix with a higher growth factor 
concentration.95  
 Platelet Concentrate Classification 
Different centrifugation speeds and times with or without the addition of chemical additives 
produces different types of platelet concentrates.19 To help understand the different types 
of platelet concentrates, Ehrenfest et al.  have proposed a simple classification system.90 
The classification system is based on: 1) The pharmacological content (platelets and 
leukocytes) of the concentrate and 2) The characteristics of its fibrin network.90 
Platelet concentrates are classified into four main categories.90 
1. Pure Platelet-rich plasma (P-PRP), also known as Leukocyte-poor plasma. 
2. Leukocyte-and Platelet-rich plasma (L-PRP).  
3. Pure platelet-rich fibrin (P-PRF), also known as Leukocyte-poor fibrin. 
4. Leukocyte-and Platelet-rich fibrin (L-PRF). 
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2.6.2.1 Pure Platelet-rich plasma (P-PRP) or Leukocyte-poor plasma 
P-PRP has a complex preparation protocol involving multiple steps with the addition of 
chemicals. Preparation is not easy, can be very expensive and lack reproducibility. Platelet 
collection is low and platelets are damaged in the preparation process. Also, there are limited 
publications on its use. Examples of P-PRP are: Vivostat PRF and Anitua’s PRGF.90, 91 
2.6.2.2 Leukocyte-and Platelet-rich plasma (L-PRP) 
L-PRP is not commonly used and its preparations kits are inconvenient, inefficient, 
expensive and the resultant concentrate dissolves rapidly.90 Examples of this concentrate 
are: Curasan, Regen PRP and Plateltex.90 
2.6.2.3 Pure platelet-rich fibrin (P-PRF) or Leukocyte-poor fibrin 
The trade name for P-PRF is Fibrinet. Its claim to fame is that it is a ‘natural’ platelet 
concentrate as it is void of bovine thrombin. However, its preparation still requires an 
anticoagulant and separation gel and therefore cannot be defined as ‘natural’. Its 
preparation is difficult and expensive. There is also a lack of evidence in the literature on the 
efficacy of Fibrinet.90 
2.6.2.4 Leukocyte- and Platelet-rich fibrin (L-PRF) 
L-PRF is Choukroun’s PRF. Its protocol is the simplest and most inexpensive of all platelet 
concentrates. It is a wholly autogenous and a natural biomaterial. There are no added 
anticoagulants or gelling agents. The resultant fibrin clot has a strong resilient matrix with a 
3-dimensional structure and a high concentration of platelets and leukocytes. The PRF 
preparation process activates the platelets inducing platelet and leukocyte growth factors to 
be implanted into the fibrin matrix. PRF, when compared to PRP, has an extended working 
time as the resultant clot does not dissolve quickly. The PRF protocol is easily reproducible 
and well suited for widespread applications.90 Its use has been well documented over recent 
years and includes sinus floor elevation, extraction socket preservation and augmentation,  
intrabony and furcation defects, peri-implant defects, regenerative endodontic treatment, 
root end surgery and soft tissue augmentation.12, 18 
With its increasing popularity and a rise in commercial interests, there are several PRF kits 
available. The most common is Choukroun’s PRF with a kit from Duo Process, Nice, France. 
Choukroun’s protocols have evolved over time and include Choukroun’s PRF; Advanced PRF 
 28 
 
(A-PRF), and injectable i-PRF.90 Other variants to PRF are L-PRF by Intra-spin and CGF which 
is a solid fibrin material enriched with leukocyte and was created by Sacco.95  
This research report will focus on Choukroun’s A-PRF. 
2.7 Platelet Rich Fibrin 
PRF preparation has evolved over time and different protocols are in use.87 It has been 
shown that altering the centrifugation forces alters the distribution of the different cell 
types.96 These different protocols attempt to optimize the ratios of blood cells, growth 
factors and cytokines within the fibrin matrix. This creates optimal PRF preparations specific 
to different clinical requirements.19  
The current PRF protocols are:87 
1. The original Choukroun’s PRF protocol (standard protocol): 3000 rpm / 10 minutes 
2. Dohan Ehrenfest’s PRF (L-PRF): 2700 rpm / 12 minutes) 
3. Choukroun’s advanced PRF (A-PRF): 1500 rpm / 8 minutes 
4. Choukroun’s i-PRF (solution/gel form): 700 rpm/3 minutes 
PRF is an autogenous living biomaterial.17 It can be described as an optimised blood clot 
made up of a 3-dimensional fibrin matrix enriched with platelets, cytokines, growth factors,  
leukocytes and stem cells.19, 96 
PRF is prepared from a patient’s own blood. A small amount (9-10 ml) is extracted and 
undergoes centrifugation. The centrifugation process separates the blood into three distinct 
layers: an acellular supernatant plasma layer on top, a PRF clot in the middle and an 
erythrocyte layer at the bottom. The PRF clot is made up of two distinct parts: a yellow 
fibrin clot and a smaller red thrombus at its base. Between these two parts, there is a 
whitish layer called the buffy coat. The PRF clot can be used directly as is or it can be 
compressed into a membrane or plug depending on the clinical application. The supernatant 
can be aspirated and used as an injectable (i-PRF).19 
Choukroun et al. summarised the clinical observations of PRF as inducing angiogenesis, 
enhancing natural immune support, harnessing the power of circulating stem cells and 
enhancing epithelial cover to protect the wound.17 The authors state that it is not only the 
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platelets, growth factors and cytokines within the PRF clot that provide these benefits but 
that its fibrin gel matrix is the key component. 
 Structural Components of the PRF clot 
The centrifugation process separates the different blood constituents into three layers: an 
acellular supernatant plasma layer, a middle PRF clot layer and erythrocytes below.  
 
Figure 2.9: The three layers immediately after centrifugation. 
 
PRF is made up of a yellow fibrin clot with a red thrombus base and a whitish buffy coat 
between the two. 
 
 
Figure 2.10: The PRF clot. 
Acellular 
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PRF clot 
Erythrocytes 
Yellow fibrin clot 
Red thrombus 
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Figure 2.11: Illustration of the PRF clot.97 
The PRF clot is a 3-dimensional fibrin matrix consisting of platelets, cytokines, growth 
factors, leukocytes and stem cells.19, 96  
  Benefits of PRF 
2.7.2.1 PRF as a Tissue Regenerator 
Tissue healing and regeneration requires mutual interactions between a scaffold, platelets, 
growth factors, leukocytes and stem cells.18 These essential components are all found within 
PRF and are able to enhance tissue healing and regeneration. The key element of PRF is its 
3-dimensional fibrin matrix.17 This type of matrix gives PRF its great density, elasticity, 
flexibility and strength making it well suited for manipulation, handling and suturing.18 In 
addition, the fibrin matrix serves as a scaffold providing a unique delivery system that 
gradually releases the trapped cytokines and growth factors necessary for healing.87 It 
allows for the biological signals and cellular interactions necessary for healing and 
regeneration i.e. cell proliferation, differentiation, extracellular matrix synthesis, chemotaxis 
and angiogenesis.87 In addition, this fibrin matrix is able to act as an extracellular matrix 
creating an environment suitable for healing. Furthermore, as a scaffold for cellular 
interactions the fibrin matrix connects the different components within its structure to the 
local tissues accelerating neo-angiogenesis. This, in turn, enhances tissue healing and 
regeneration.19 
Dohan et al. explained this 3-dimensional fibrin structure.88 During polymerisation, fibrin 
fibrillae connect in one of two ways: bilateral junctions or equilateral junctions.88, 90 The 
Buffy coat 
Red thrombus 
Fibrin clot 
 31 
 
ratio between fibrinogen and thrombin influences the rate of polymerisation. High thrombin 
concentrations initiate rapid fibrin polymerisation resulting in the fibrin fibrillae arranging 
themselves with bilateral junctions.90 This creates a dense rigid fibrin network which is 
unfavourable to cytokine entrapment and cellular interactions. This type of arrangement 
occurs in PRP preparations.90  
PRF, on the other hand, has low thrombin concentrations allowing for a more natural 
polymerisation rate, creating a higher percentage of equilateral junctions.90 These junctions 
create an elastic fibrin network which supports cellular entrapment and migration. This 
elastic biomaterial is, therefore, a strong, flexible and malleable material that can be 
manipulated into a suitable delivery vehicle.88, 90 This quality allows PRF to be manipulated 
and compressed into a membrane or plug to fit the clinical need and support wound 
healing.93  
PRF is rich in cytokines and growth factors. Various growth factors have been identified in 
the PRF clot: transforming growth factor-beta 1 (TGF-β1), platelet-derived growth factor 
(PDGF), insulin-like growth factors (IGF), vascular endothelial growth factor (VEGF), 
epidermal growth factor (EGF) and fibroblast growth factor (FGF).11, 15, 92, 97 These growth 
factors lie within the dense leukocyte fibrin meshwork which delivers the slow release of 
growth factors and cytokines.89 These PRF properties promote homeostasis and wound 
healing supporting the immune response by enhancing cellular migration and proliferation, 
angiogenesis and regulating post-surgical inflammation.15, 98  
Dohan et al. studied the distribution of platelet cytokines and found that these cytokines 
remain trapped within the fibrin meshwork and suggest that they may also be in the fibrin 
polymers.97 Plasma analysis have shown that the supernatant and erythrocyte layers are 
void of platelets.97 It was found that platelets accumulate in the lower part of the fibrin clot 
known as the buffy coat. It appears as whitish lines which correspond to the accumulation 
of platelets.97 The authors then explain this phenomenon. PRF processing involves 
extracting blood into glass tubes and these residual glass particles induce immediate 
massive platelet activation. Platelet cytokines are small particles which imply that during 
centrifugation, they would accumulate in the top part of the tube i.e. the supernatant layer. 
However, plasma analysis showed that the supernatant is void of cytokines. Therefore, they 
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deduced that the cytokines integrate into the fibrin polymer molecular structure i.e. 
cytokines are trapped within the PRF fibrin matrix.97 
2.7.2.2 PRF as an Extracellular Matrix 
Angiogenesis is a complex biological process involving varied cellular interactions. Migration, 
proliferation and differentiation of endothelial cells are necessary to develop new blood 
vessels. In addition, a healthy extracellular matrix (ECM) is critical to support these 
processes. The ECM is the interstitial matrix between cells and between the basement 
membrane and its adjacent layers. The basic constituents of the ECM are: collagen, elastin, 
proteoglycans, hyaluronan, glycoproteins such as fibronectin and laminin and adhesion 
receptors such as integrins. Certain components of the ECM are involved in wound healing 
and tissue repair. These components are the proteoglycans which act as a reservoir for 
growth factors, glycoproteins and integrin receptors which serve to control cell interactions.   
In summary, the functions of the ECM are:99 
 To provide mechanical support for cell anchorage, migration and maintain cell 
polarity. 
 To regulate cellular proliferation and differentiation. 
 To provide a scaffold for tissue renewal. 
 To create micro tissue compartments and environments. 
Choukroun et al. claim that the PRF clot can act as an ECM.17 Its 3-dimensional structure is 
enmeshed with cytokines and growth factors and provide similar functions as the ECM. Just 
as the ECM acts as a support structure supplying the necessary growth factors inducing 
angiogenesis, so too does the PRF clot act as a support structure to angiogenesis promoting 
cellular interactions.17 PRF is also a reservoir for the necessary cytokines and growth factors. 
The authors also explain that fibrin itself is an important angiogenic conductor.17 Fibrin 
stimulates expression of the integrins involved in angiogenesis. These integrins bind to the 
ECM components initiating signalling cascades that influence the cellular processes of 
angiogenesis.99 Studies have shown that the fibrin within the PRF clot binds to growth 
factors such as FGF-2 and PDGF with high affinity inducing angiogenesis.17  
A PRF clot provides angiogenic support to wounds similar to the way the ECM supports 
angiogenesis. The PRF clot is enmeshed with trapped cytokines and angiogenic growth 
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factors. Angiogenesis is the formation of new blood vessels from existing blood vessels and 
is essential for healing and tissue repair.99 There are various growth factors involved in 
angiogenesis. Important growth factors are VEGF, FGF, PDGF and angiopoietins (Ang); Ang1 
and Ang2.17 These growth factors have been identified in PRF preparations.97, 98, 100 
In vitro studies have shown that the structural and mechanical properties of the fibrin 
matrix affect angiogenesis.17 The more rigid the matrix, as in the case of PRP or fibrin glues, 
the less supportive it is to new capillary formation. PRF, on the other hand, undergoes a 
slow polymerisation process and the resultant biomaterial is elastic. The elastic nature of 
PRF is favourable to cell proliferation and migration and therefore favourable to new 
capillary formation.17, 97  
2.7.2.3 PRF as an Immune Enhancer 
PRF acts as an adjunct to wound healing aiding the immune response.  Dohan et al. found 
that there was an increase secretion of these cytokines within the PRF clot.98 As these 
cytokines are leukocytic in origin, it can be inferred that the PRF process causes leukocyte 
activation and degranulation.98 These cytokines are then entrapped within the fibrin 
network during PRF processing and are slowly released during healing. The authors 
conclude that PRF can be considered as an inflammatory regulator and immune response 
stimulator.98  
 Choukroun et al. also explain that fibrin is a natural immune enhancer.17 Fibrin has positive 
effects on inflammation. It has been shown that fibrin and fibrinogen degradation products 
stimulate neutrophil migration, adhesion and transmigration. Fibrin degradation products 
also promote phagocytosis of neutrophils. Fibronectin and chemotactic substances that are 
trapped within the fibrin matrix promote macrophage wound colonisation. These actions 
have been documented by the accelerated wound healing properties of PRF.17  
In vitro studies have shown that fibroblasts are able to migrate efficiently within a fibrin gel 
culture model system.101 The fibrin culture was able to stabilise, reorganise and produce a 
matrix similar to that of naturally repairing tissue.101 The PRF fibrin gel matrix behaves 
similarly by organising into a strong fibrin clot providing a scaffold for epithelial cell 
proliferation and ultimately wound coverage.17  The fibrin matrix directs epithelial coverage 
by altering the metabolic processes of epithelial cells and fibroblasts. In summary, PRF 
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stimulates angiogenesis, epithelial cell migration and collagen synthesis while providing 
enhanced immune support. These properties are best demonstrated in a tooth extraction 
socket where it has been reported that PRF treated sockets heal quicker with reduced pain, 
dryness or purulent complications than sockets without PRF.17 
2.7.2.4 PRF as a Source of Circulation Stem Cells 
In healthy individuals, haemorrhage leads to haemostasis. The resulting fibrin blood clot 
traps circulating stem cells. Stem cells are created in bone marrow and are mesenchymal in 
origin. They have the ability to differentiate into various cell types depending on the signals 
they receive. Stem cells are an integral part of the healing and repair process.99 Similar to a 
natural blood clot, PRF is a naturally derived fibrin matrix which also traps circulating stem 
cells. It has been demonstrated that the PRF fibrin matrix provides optimal support for stem 
cells to differentiate.17 Clinically, PRF has the potential to surpass the natural healing 
phenomenon. A PRF clot is better organised than a natural blood clot and so able to direct 
stem cell activities more efficiently, accelerating the healing process.17 
2.7.2.5 PRF as a Healing Biomaterial 
Choukroun et al. summarise the benefits of PRF as conducive to all types of superficial 
cutaneous and mucous membrane healing.17 With its molecular structure, PRF provides an 
optimal fibrin matrix for endothelial cell and fibroblast migration, it supports rapid 
angiogenesis and easily remodels fibrin into a stronger connective tissue.17  
Dohan et al. state that a PRF clot is more supportive to healing than natural fibrin clots.97 
The authors explain that the PRF centrifugation process allows for slow polymerisation of 
the fibrin and hence greater integration of cytokines into the fibrin network. This integration 
enables these cytokines to be kept in situ until healing is initiated. Once healing is initiated 
and the fibrin matrix undergoes remodelling, these cytokines are progressively released 
from the PRF clot. In this way, the lifespan of the entrapped cytokines are increased.97 These 
cytokines play a key role in healing as they are anti-infectious and can regulate the immune 
response.90 The PRF matrix with its molecular and cellular components provides synergistic 
effects on healing.97  
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A key factor in healing is inflammation. Inflammation is a protective immune response to 
any injury. There are three key inflammatory phases: vascular phase, cellular phase and 
healing phase.98 
The vascular phase of inflammation is characterised by vasodilation and increased vascular 
permeability.99 These vascular changes result in an increase of leukocytic cells at the wound 
site which secrete inflammatory cytokines and growth promoters. Similarly, a PRF clot 
contains these cell mediators.98    
Dohan et al. studied the distribution of the five key cell mediators within PRF.98 The 
following cytokines were identified: Interleukin-1β (IL-1β), interleukin-6 (IL-6), tumour 
necrosis factor α (TNF-α), interleukin-4 (IL-4) and VEGF.98 
IL-1β, IL-6 and TNF-α are pro-inflammatory mediators. These cytokines are produced by 
leukocytic cells in response to tissue injury and promote expression of selectins and 
integrins on endothelium, increase avidity of integrins for their ligands and promote 
chemotaxis.99 The combination of these effects promotes inflammation, cellular destruction 
and remodelling.98 IL-4 is an anti-inflammatory mediator and inhibits the inflammatory 
signal pathways and counteracts their amplification.98 VEGF is an angiogenic growth 
promotor important in the healing phase of inflammation and promotes endothelial cell 
proliferation, migration and differentiation.98 VEGF is a potent angiogenic initiator and is 
involved in the development of initial healing structures.98 Hence, PRF has the necessary 
cytokines to support inflammation and healing. These inflammatory regulators may also 
decrease post-operative pain making the post-operative phase of healing more tolerable to 
patients.98, 102 
It can be said that PRF is a “healing” biomaterial.17, 89, 97 PRF membranes are cost-effective to 
produce with a short chairside time and can make periodontal surgery affordable. PRF is 
being used increasingly by clinicians as an adjunctive autologous biomaterial to enhance 
bone and soft tissue healing and regeneration.18 The most widely reported PRF technique is 
Choukroun’s PRF with his latest updated protocol being Advanced PRF (A-PRF).89   
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2.8 Platelets and Cytokines  
Platelets are normally found in circulating blood and are discoidal, anuclear cell fragments 
produced by megakaryocytes in bone marrow.99  Platelets are primarily involved in 
haemostasis. Activated platelets aggregate at an injured site forming a haemostatic plug. 
This seals vascular defects and creates a surface to recruit and concentrate coagulation 
factors. Platelets consist of a contractile cytoskeleton, cytoplasmic granules and have a  
double phospholipid membrane layer which serves as receptor sites for many molecules.97, 
99 
A platelet’s primary function ultimately leads to the coagulation cascade. However, its 
activation releases cytokines contained within its cytoplasmic granules. These cytokines 
stimulate cellular migration and proliferation initiating wound healing and tissue repair.97 
Platelets have two types of cytoplasmic granules:  
1. α granules which contain platelet specific and non-platelet specific proteins. Platelet 
specific proteins are β-thromboglobulin and non-platelet specific proteins are 
fibrinogen, fibronectin, coagulation factors, PDGF, TGF-β, thrombospondin, and 
various other growth promotors 
2. δ granules which contain adenine nucleotides, calcium, serotonin, histamine and 
epinephrine.97, 99  
On activation, platelets aggregate at the injury site initiating and supporting haemostasis 
and undergoes degranulation releasing its cytokines to stimulate cellular interactions within 
the fibrin matrix and is critical for the initial phase of healing.97  
In PRF preparation, the centrifugation forces expose platelets to the glass tube wall thereby 
initiating their activation. In the absence of anticoagulant, there is massive platelet 
activation and these activated platelets up-regulate tissue factor expression of leukocytes. 
As the platelets activate, their α-granules burst releasing cytokines and the various growth 
factors contained within these granules.89   
 Transforming Growth Factor β (TGF-β) 
The TGF-β superfamily is a large group of cell regulatory proteins with more than thirty 
isoforms. The most commonly produced isoform is TGF-β1. It is produced in platelet α-
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granules and has pleiotropic functions.103 TGF-β1 is a potent fibrosis mediator and induces 
increased synthesis of collagen type 1 and fibronectin in osteoblasts and fibroblasts.97 It also 
induces fibrin matrix remodelling in wound repair. TGF-β1 supports angiogenesis by 
suppressing endothelial cell proliferation and migration and increases extracellular matrix 
(ECM) protein production.99 TGF-β1 is intricately involved in the fibrous healing process and 
considered to be a key regulator of inflammation and wound healing.97, 103  
 Platelet Derived Growth Factor (PDGF) 
PDGF regulates cellular migration, proliferation and survival of mesenchymal cell lineages. 
Their specific receptor systems enable them to be either cell stimulators or inhibitors 
depending on which receptor is engaged. Hence, PDGF plays a critical role in regulating 
development during embryogenesis and in physiological tissue remodelling during healing.97 
PDGF also plays a role in angiogenesis by recruiting smooth muscle cells and thereby 
enabling new blood vessel maturation.99 
 Insulin-like Growth Factors (IGF) 
IGF I and II functions as growth factors and hormones of energy metabolism and in this way 
positively regulates cellular proliferation and differentiation of most cell types.89, 97 IGF also 
induces surviving signals which protect cells from matricial apoptotic stimuli and in this way 
is an important apoptotic regulator.97  
 Vascular Endothelial Growth Factor (VEGF) 
VEGF is a family of growth factors that include VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E 
and placental growth factor (PIGF).99 VEGF-A is an important initiator of angiogenesis 
following injury and is most commonly referred to as VEGF. VEGF-C and –D initiate 
angiogenesis and lymphangiogenesis while VEGF-B and PIGF is involved in embryonic 
angiogenesis.99 
VEGF has a three-fold mechanism of action. It initiates angiogenesis by directly stimulating 
proliferation, migration and differentiation of endothelial cells, stimulates vasodilation by 
producing nitric oxide and aids in development of the vascular lumen.99 VEGF is also 
important for endothelial cell survival and its various isoforms allow it to guide the 
development of the capillary network and its branches.98   
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 Fibroblast Growth Factor (FGF) 
FGF is a family of 20+ subtypes and its most common isoforms are acidic FGF (FGF-1) and 
basic FGF (FGF-2).99 FGF-2 is involved in angiogenesis by stimulating proliferation of 
endothelial cells. FGF-2 also induces migration of macrophages and fibroblasts to the injury 
site and stimulates epithelial cell proliferation.99  
 Angiotensin 1 and 2 (Ang1 and Ang2)  
Ang1 and Ang2 are involved in angiogenesis. Angiogenesis is a key biological process for 
normal development, wound healing and organ regeneration.100 Angiogenesis is involved in 
the development and structural maturation of new blood vessels.99 
2.9 The Importance of Cytokines in PRF 
Dohan et al. undertook a study to determine the distribution of these cytokines within the 
different parts of the PRF layers i.e. the supernatant layer, the PRF exudate (by allowing the 
PRF solution time to exude out of the clot) and the PRF clot itself.97 After PRF processing 
each layer was examined. The authors concluded that the cytokines remained trapped 
within the fibrin matrix and deduced that they must be intricately enmeshed within the 
fibrin polymers.97 The fibrin clot was then stained with alcian blue and this revealed the 
distribution pattern of the glycoproteins and glycanic chains within the PRF clot.  These 
molecules were trapped within the fibrin mesh following the fibrillary architecture of the 
mesh. Such an intricate distribution of the cytokines imply an increased lifespan of these 
cytokines as they would only be released at the time of matrix remodelling aiding cellular 
proliferation and migration during healing.17, 97 
In sum, various platelet cytokines are trapped within the PRF fibrin matrix and polymers. 
These cytokines play vital roles in homeostasis, inflammation, wound healing and tissue 
repair. By using PRF, there is the potential to use the slow release of these cytokines to 
amplify and improve post-surgical healing. PRF is thought to be a healing biomaterial.17 Can 
these properties enhance the surgical outcomes of periodontal plastic surgery? Hence, I was 
prompted to test this hypotheses clinically to determine if PRF can improve surgical 
outcomes in treating gingival recessions. 
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2.10 Aesthetic evaluation of surgical results 
Soft tissue aesthetics is not routinely evaluated after gingival recession surgery.13, 104 
However, with increasing aesthetic demands of patients and clinicians, it is advantageous to 
evaluate and compare aesthetic results between different surgical techniques.  
The proverb, “beauty is in the eye of the beholder”, aptly describes the subjective nature of 
acceptable aesthetics. The idea of what personifies beauty is intrinsically subjective and can 
be intensely affected by cultural factors.105 There are limited studies that have 
systematically evaluated aesthetic outcomes using any type of visual scoring system. Studies 
simply comment on aesthetic outcomes using general terms such as ‘‘aesthetically pleasing’’ 
and ‘‘good aesthetic results’’.72 In a study by Rosetti et al. aesthetic results were evaluated 
on a good, regular and poor scale.106 Most sites (80%) were rated as good and 20% of sites 
were rated regular, no sites were rated poor. The authors state that this scoring system is 
dependent on a subjective clinical impression.106 Also, the degree of aesthetic expectations 
can vary not only between patients and clinicians but between different clinicians as well. 
Fürhauser et al. set out to determine the objectivity and reproducibility of an aesthetic 
scoring system: the Pink Esthetic Score.107  Four different types of dental observers 
(prosthodontists, orthodontists, oral surgeons and dental students) were asked to evaluate 
aesthetics using photographs. It was found that orthodontists are the most critical assessors 
of soft tissue aesthetics.107 Therefore, a more objective means of assessing aesthetics is 
needed. Kerner et al. stated that a before and after scoring system is a reliable and 
adequate way of evaluating aesthetic outcomes.108 
There are two scoring systems that may be used to assess gingival aesthetics. 1) The root 
coverage esthetic score (RES) and 2) The pink esthetic score (PES). 
 The RES System 
The RES system was proposed to evaluate aesthetic outcomes of root coverage procedures. 
This scoring system uses five variables to evaluate gingival aesthetics: gingival margin, 
marginal tissue contour, soft tissue texture, MGJ alignment and gingival colour.104 Points are 
allocated as follows: with regards to gingival margin, 6 points for complete root coverage, 3 
points for partial root coverage and 0 points for no root coverage. The remaining variables 
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are scored in the following way: 1 point for a normal appearance of the tissue and 0 points 
when the tissue deviates from this. The highest possible score is 10 points.  See table below. 
Table 2.1: Root Esthetic Score by Cairo et al.104 
 
 The PES System 
The PES system is an alternative scoring system to evaluate gingival aesthetics. This scoring 
system was created to evaluate the soft tissue around single-tooth implant crowns.107 Since 
successful aesthetic outcomes (whether on an implant or after root coverage procedures) is 
determined by how close to natural a tooth looks, its application may be extended to 
evaluate aesthetic outcomes of root coverage procedures.  This system uses a seven 
variable system to evaluate aesthetics: mesial papilla, distal papilla, level of soft tissue 
margin, soft tissue contour, alveolar process, soft tissue colour, soft tissue texture.107 The 
scoring system is a 2-1-0 score with 2 being the best and 0 being the worst. Variables are 
assessed in comparison to a reference tooth, which can be the corresponding tooth in 
another quadrant or the adjacent tooth. The highest possible score is 14 points. See Table 
below. 
  
Variables Description 
Gingival margin  
0 points: root coverage failed i.e. the gingival margin is apical or equal to 
the baseline level and/or if there was complete or partial loss of the 
interproximal papilla.  
  3 points: partial root coverage. 
  
6 points: complete root coverage with the gingival margin at or slightly 
coronal to the CEJ and the site has a physiological sulcus depth. 
Marginal Tissue Contour 0 points: irregular gingival margin that does not follow the CEJ.  
  1 point: the gingival margin follows the CEJ contours.  
Soft Tissue Texture 0 points: scars or keloids impair the gingival appearance. 
  1 point: normal gingival texture.  
Mucogingival junction 
alignment 
0 points: MGJ of the tooth in question does not line up with the MGJ of 
adjacent teeth. The new MGJ is either coronal or apical to the adjacent 
MGJ.  
  1 point: the MGJ lines up with the adjacent MGJ. 
Gingival Colour 0 points: the grafted tissue is a different colour from the adjacent tissue. 
  
1 point: the grafted tissue matches the adjacent tissue in colour and is well 
integrated.  
 41 
 
Table 2.2: Pink Esthetic Score by Fürhauser et al.107 
Variables Details 0 1 2 
Mesial papilla 
Shape vs reference 
tooth Absent Incomplete Complete 
Distal papilla 
Shape vs reference 
tooth Absent Incomplete Complete 
Marginal 
Tissue Level Level vs reference tooth 
Major 
discrepancy 
>2mm 
Minor 
discrepancy 1-
2mm 
No 
discrepancy 
<1mm 
Soft Tissue 
Contour 
Natural matching 
reference tooth Unnatural Fairly natural Natural 
Alveolar 
Process 
Alveolar process 
deficiency Obvious  Slight None 
Soft Tissue 
Colour 
Colour vs reference 
tooth 
Obvious 
difference 
Moderate 
difference No difference 
Soft Tissue 
Texture 
Texture vs reference 
tooth 
Obvious 
difference 
Moderate 
difference No difference 
 
On photographs, it can be challenging to determine the MGJ because the border between 
the keratinised tissue and the alveolar mucosa is often unclear. Cairo et al. tested the 
predictability of the RES with photographs and found that the assessment of the MGJ 
position varied amongst examiners.109 The authors attributed this discrepancy to the 
difficulty in determining the MGJ on photographs.109  Hence, to avoid this bias, this study 
used the PES to evaluate aesthetic changes.  
2.11 Modified Tunnel Flap 
CAF’s provide the most predictable and improved aesthetic outcomes in correcting gingival 
recessions.3 This technique was first described by Langer and Langer.71 Their technique 
produced predictable and acceptable outcomes. This technique uses vertical relieving 
incisions to mobilise the flap and these incisions can result in scarring compromising 
aesthetics. In a study by Zucchelli et al. where CAFs with and without vertical incisions were 
compared, the authors found that keloid formation due to the vertical incisions resulted in 
the poorest aesthetic outcomes.110 In 1985, Raetzke introduced the envelope flap 
eliminating the vertical incision.74 This technique was simple and improved aesthetic results. 
However, the envelope flap is used to treat single recession lesions. In 1994, Allen modified 
this flap design by connecting multiple adjacent envelope flaps to create a tunnel flap.111 
This flap design allows for multiple adjacent recession lesions to be treated at once. Then, in 
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1999, Zabalegui described connecting multiple envelope flaps while keeping the interdental 
papilla intact creating the modified tunnel flap.112 This type of flap is minimally invasive and 
prevents potential scarring improving the aesthetic result. In addition, Zuhr et al. state that 
the blood supply to the graft tissue is the key element to the success of this procedure.113 A 
modified tunnel flap avoids vertical and horizontal incisions preserving continuity of the 
collateral blood supply to the graft allowing for improved healing.114 Zucchelli et al. in their 
study to compare outcomes between CAF’s with and without vertical relieving incisions, 
found that although both techniques were effective in improving recessions, the envelope 
type CAF increases the probability of complete root coverage with an improved result.110  
In recent years there has been a shift towards microsurgical dentistry. This concept uses 
microsurgical instruments, materials and visual aids to allow more delicate and precise 
access to the surgical site potentially improving clinical and aesthetic outcomes.113 Tunnel 
flaps which are created with microsurgical blades and specially developed tunnelling 
instruments allow for precise intrasulcular incisions which can help minimize soft tissue 
ruptures that would compromise aesthetic results.113 Burkhardt and Lang compared 
microsurgical and macrosurgical techniques in treating recessions and found that the 
microsurgical approach improved vascularisation of the grafts minimizing the risk of graft 
necrosis thereby improving wound healing.115  
In this study a modified tunnel flap was created with microsurgical instruments in order to 
minimise postoperative scarring to allow for the best possible clinical and aesthetic 
outcomes. 
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CHAPTER 3 
3 AIMS AND OBJECTIVES 
3.1  Aim 
To evaluate the clinical efficacy of PRF membranes and CTGs in treating gingival recession. 
3.2 Hypothesis  
PRF membranes can be as effective as CTGs in gingival recession treatment with improved 
aesthetic results. 
3.3 Objectives 
1 To determine the clinical efficacy of PRF membranes in treating gingival recession.  
2 To evaluate clinical and aesthetic outcomes between the control and test within each 
patient.  
3 To determine patient satisfaction with regards to aesthetic outcomes between the 
control and test groups. 
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CHAPTER 4 
4 METHODS AND MATERIALS 
4.1 Study design 
This project is an extended case series designed as a randomised split-mouth study to 
evaluate the clinical efficacy of PRF membranes and CTGs in treating gingival recessions. 
4.2 Study population  
Patients over the age of 18 years who presented at the Wits Oral Health Centre and fulfilled 
the selection criteria. 
4.3 Sampling 
All patients that fulfilled the selection criteria were invited to participate in this study. 
 Inclusion criteria 
 Patients who presented with at least two Miller’s class I and/or class II gingival 
recession lesions that were bilateral or contralateral to each other but not excluding 
recession lesions that were in the same quadrant and a reasonable distance apart. 
{The interdental papilla level is the most significant prognostic factor for root 
coverage.46 In lesions with interdental papilla loss, the aesthetic outcome is 
compromised as only partial root coverage is predicted. Therefore, in order to 
effectively test clinical outcomes between the groups, only Miller’s class I and II 
lesions (see page 10) were included in the study.}   
 Patients who were at least 18 years old. 
 Patients who were willing to give written informed consent. 
 Patients who were in good systemic health. 
 Patients with good periodontal health.  
 Non-smokers.  
 Patients who were motivated and able to maintain good oral hygiene. 
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 Exclusion criteria 
 Those patients who presented with Miller’s class III and class IV (see page 11) 
gingival recessions. 
 Pregnancy. 
 Patients with bleeding disorders. 
 Recession sites on posterior teeth with furcation involvement.  
 Patients who have had previous periodontal surgery in an attempt to correct gingival 
recessions in the areas of interest. 
4.4 Patient recruitment and enrolment 
Patients were sourced from the Wits Oral Health Centre. Patients with gingival recession 
lesions were identified and screened to determine if they qualified for the study as per the 
inclusion and exclusion criteria. Once identified, the study was explained to patients with 
possible alternative treatment options and if interested in this surgical treatment, they were 
enrolled into the study. Informed consent was obtained with signed consent forms 
(appendix 1).  A case report file was created for each patient where all relevant information 
was kept and recorded with anonymity. Patient names were not recorded on the case 
report file and a reference code was assigned to each file to ensure anonymity. This case 
report form had a detailed breakdown of each appointment (appendix 2). A clinical checklist 
was used to ensure all necessary procedures were carried out at the relevant appointments 
(appendix 3).  
A comprehensive clinical examination was carried out on each patient.  Aetiological factors 
were identified and addressed accordingly. A scale and polish was done and patients were 
given oral hygiene instructions and motivation. 
The plaque control in these patients were ≤20% 116 and well controlled. These patients were 
instructed to use a soft bristle toothbrush with the modified Bass brushing technique.48 The 
toothbrush is placed at 45° angle to the long axis of the tooth in an apical direction partly 
covering the gingiva and the cervical area of the tooth. The toothbrush is moved with short 
back and forth strokes rolling over the gingiva in an occlusal direction with light pressure.48  
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Photographs and alginate impressions were taken. The laboratory work was done at the 
Wits Dental Laboratory. Acrylic palatal stents and measuring guides (see figures 4.1 and 4.2) 
were made. The palatal stent was used to protect the palatal donor site post-surgery and 
the measuring guides were used to ensure reproducible clinical measurements. Each 
recession lesion was identified clinically. Some patients had lesions in all four quadrants and 
these were paired and each recession recorded as a separate site.  
 
Figure 4.1: Acrylic palatal stent in place to protect palatal surgical wound. 
 
Figure 4.2: Acrylic measuring guide with probe. 
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4.5 Randomisation  
Once patients agreed to take part in this study, their anonymity was ensured by giving each 
patient an alphabetical reference i.e. A, B, C, D, E or F.  Each paired site was given a 
numerical value from 1 to 11 (e.g. A1, B2, C3 etc. see appendix 5) and randomly allocated to 
the control or test site using the RAND function in Microsoft Excel 2016, see figure 4.3.  
 
Figure 4.3: Example of randomisation function using Microsoft Excel 2016. 
 
4.6 Clinical measurements 
The clinical measurements were recorded using a University of North Carolina probe (UNC 
15). This probe is 15mm long with shaded markings at every mm and wider shaded bands at 
5, 10 and 15mm.  
 
Figure 4.4: University of North Carolina probe (UNC 15). 
The probe was placed within narrow grooves created on the buccal aspect of the measuring 
guide (see figure 4.2).  
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The following parameters were measured and recorded to nearest millimetre (mm): 
 Periodontal probing depths (PD)  
PD were measured at three points: mesiobuccal (MB), mid-buccal (B) and distobuccal (DB). 
Periodontal probing depth is the distance measured from the gingival margin to the base of 
the gingival sulcus.117  
 Recession depth (RD)  
Recession depths were measured at three points: MB, B, and DB. Recession depth is the 
distance from the CEJ to the gingival margin.117 Identifying the CEJ can be challenging. The 
CEJ can be lost due to tooth brushing habits that erode enamel or a restoration may mask 
the junction. In scenarios where the CEJ was lost, the crown lengths of adjacent or 
contralateral teeth were used as a guide to determine the position of the CEJ.  
 The clinical attachment level (CAL)  
CALs are indicators of periodontal tissue destruction and can also be used to monitor 
disease progression and tissue response to periodontal therapy.118 CAL is measured from 
the base of the sulcus to the CEJ (which is a fixed point and does not change throughout 
life). The aim of periodontal therapy is to increase periodontal attachment and this can be 
determined by a ‘gain’ or ‘loss’ in CALs.  
In this study, the CAL was recorded as clinical attachment loss. CALs are calculated by adding 
the probing depth to the recession depth values.47 The CAL values were determined at three 
points: MB, B, and DB. 
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Figure 4.5: Diagrammatic representation of CAL117 
 
 Recession width (RW)  
RW was measured at the widest horizontal distance from the mesial to distal margins of the 
recession defect.6  
 Keratinised tissue width (KTW).  
The MGJ was determined with a combination of the visual and rolling method.35, 119 The 
visual method involves identifying the colour change between the alveolar mucosa and the 
keratinised gingiva. The keratinised gingiva is a pale pink coral colour. In contrast, alveolar 
mucosa is darker, shiny and smoother than keratinised gingiva. In the rolling method, the 
side aspect of the UNC-15 probe was used to gently “roll” the gingiva horizontally from the 
vestibule towards the gingival margin. This action causes the loose alveolar mucosa to roll 
and the mucogingival line is then identified at the point where this movement stops creating 
a crease and the attached gingiva is immoveable.35 The KTW was measured along the 
vertical mid-buccal groove of the measuring guide. 
Recession Depth 
Probing Depth 
CEJ 
Gingival Margin 
Sulcus Depth  
  CAL 
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Figure 4.6: Keratinised Tissue Width 
 Gingival thickness (GT)  
GT was recorded using rubber stoppers at the end of endodontic reamers.11, 15  
 
Figure 4.7: Endodontic reamer with rubber stopper 
Under local anaesthesia, the reamer was pushed into the attached gingiva at the point 
corresponding to the vertical line of the mid-buccal groove of the measuring guide and the 
mid-point of the apico-coronal width of keratinised gingiva. Tactile sensation was used to 
determine the point at which the reamer made contact with bone. The rubber stopper 
demarcated the distance from the bone to the gingival surface and this distance was 
measured. 
  
Keratinised Gingiva 
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 Summary of variables 
Table 4.1: Clinical parameters 
Clinical Parameters Mesio-buccal (MB) Buccal (B) Disto-buccal (DB) 
PD (periodontal probing depth)* MB B DB 
RD (recession depth)* MB B DB 
CAL (clinical attachment level)* MB B DB 
RW (recession width)** 
RW was measured using a UNC 15 probe at the widest 
horizontal distance from the mesial to the distal margins 
of the recession defect  
KTW (keratinised tissue width)** KTW was measured using a UNC 15 probe along the 
vertical mid-buccal groove of the measuring guide. 
GT (gingival thickness)** 
GT was recorded using rubber stoppers at the end of 
endodontic reamers at the point corresponding to the 
vertical line of the mid-buccal groove of the measuring 
guide and the mid-point of the width of keratinised 
gingiva. 
* Variables measured at three points 
** Variables measured at one point 
All clinical measurements were independent variables and were measured in millimetres 
(mm). All measurements except GT were measured to the nearest millimetre and recorded 
at baseline pre-operatively, 8 weeks, 12 weeks, 16 weeks and 24 weeks. GT measurements 
were recorded to the nearest 0,5mm at baseline and at 24 weeks.  
Prior to surgery, a statistician randomly assigned a recession site to the control or test 
treatment. The site allocation envelope was opened at the surgical appointment.  This 
randomisation removed investigator bias. 
4.7 Evaluating and comparing aesthetics 
Photographs were taken prior to surgery and six months later at the final recall 
appointment. These were printed for evaluation. As discussed in chapter 2 (pages 39-41), 
there are two scoring systems to evaluate gingival aesthetics: the RES and PES. The RES 
system was created specifically to evaluate overall aesthetic outcomes after root coverage 
procedures. However, this scoring system uses the MGJ as one of its variables and it can be 
challenging to determine the position of the MGJ on photographs. Poor image contrast, lack 
of MGJ visibility or colour contrast increases the difficulty in clearly identifying the MGJ.109 
Cairo et al. tested the predictability of the RES with photographs and found that although 
the RES system is useful for gingival aesthetic evaluation, it posed a limitation when using 
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photographs as opposed to direct clinical assessment.109  The authors found that 
assessment of the MGJ position varied amongst assessors and attributed this to the 
difficulty in determining the MGJ on photographs.109 On the other hand, the PES system 
does not use the MGJ as a variable and was therefore used to evaluate aesthetic outcomes 
in this study.  
Table 4.2: Variables of the Pink Esthetic Score107 
Variables Details 0 1 2 
Mesial papilla 
Shape vs reference 
tooth Absent Incomplete Complete 
Distal papilla 
Shape vs reference 
tooth Absent Incomplete Complete 
Marginal 
Tissue Level 
Level vs reference 
tooth 
Major 
discrepancy 
>2mm 
Minor 
discrepancy 1-
2mm 
No 
discrepancy 
<1mm 
Soft Tissue 
Contour 
Natural matching 
reference tooth Unnatural Fairly natural Natural 
Alveolar 
Process 
Alveolar process 
deficiency Obvious  Slight None 
Soft Tissue 
Colour 
Colour vs reference 
tooth 
Obvious 
difference 
Moderate 
difference No difference 
Soft Tissue 
Texture 
Texture vs reference 
tooth 
Obvious 
difference 
Moderate 
difference No difference 
 
4.8 Patient questionnaire 
A patient questionnaire was used to determine patient satisfaction or dissatisfaction with 
the results (see appendix 4). A Likert type scale was used for analysis. Likert Scales are 
routinely used to measure attitudes with a range of responses to a particular question, 
usually a five or seven point pre-coded scale.120, 121  
This study’s questionnaire used a five point scale to evaluate the following variables: level of 
gingival recession, dentine sensitivity, gingival colour and gingival contour. See table 4.3 
below for the five point scale.  
 
Table 4.3: Likert 5 point scale for patient questionnaire 
 
Much worse 
than before 
Slightly worse 
than before No change  
Slight 
improvement 
Noticeable 
improvement 
1 2 3 4 5 
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4.9 Data analysis 
Descriptive statistics was presented for each variable in each of the six patients at baseline 
and at 24 weeks. Each patient was a unit of analysis. The outcomes for each patient was 
summarised and analysed independently. Outcomes between the baseline and 24 week 
measurements were compared in each patient. In patients with multiple paired sites 
(patient E and F), the mean of the each variable was used for statistical analysis and t-tests 
were used to compare baseline and 24 week values. In addition, the percentage root 
coverage, as well as root coverage (yes/no) was derived. 
The success of recession treatment is considered to be any decrease in the amount of 
exposed root surface.70 The primary variables that were analysed to determine this change 
was RD and RW.  
Data analysis was carried out with Microsoft Excel 2016 statistical analysis software.  A 5% 
significance level was used. The skewness and kurtosis of the distribution was considered 
while determining if the null hypothesis can be accepted. Skewness explains whether the 
distribution conforms to a typical bell curve, or is asymmetrical. Most of the data typically 
appears to be on one side of the hypothesised mean. Kurtosis describes how often samples 
may appear at either ends (the tails) of the curve. 
The patient questionnaire was based on a Likert scale.120  A Likert scale assumes that the 
power of experience is linear i.e. a patients satisfaction or dissatisfaction can be 
measured.121 It cannot be presumed that the intervals are equal.120 The data was 
summarised and analysed for each patient. As the data was ordinal, it was summarised as a 
mode in patients with multiple sites. 
4.10 Surgical procedure 
Both control and test treatments were done at the same time by the same operator. This 
was part of the research protocol so as to remove bias that may arise should different 
patients or different sites in the same patient be treated by different surgeons. Both 
recipient sites were prepared in the same way. As per discussion in chapter 2 (pages 41-42), 
a modified tunnel flap as described by Zuhr et al. was used.113  
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Once adequate local anaesthesia was achieved, intrasulcular incisions were made around 
the necks of the teeth using 15c Swann-Morton® surgical blades and Keydent® microsurgical 
discoid blades.  The incision was extended to the adjacent teeth on both sides. The flap was 
mobilised by extending it into the mucosal tissues. Hurzeler tunnelling instruments were 
used, minimizing perforations into the marginal tissues.113 The interdental papillae 
remained intact and connected. The papillae were detached from the periosteum and the 
buccal gingiva was completely mobilised allowing for tension free coronal displacement of 
the flap.  
 
Figure 4.8: 15c Swann-Morton® blade 
 
 
Figure 4.9: Keydent® microsurgical blade 
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Figure 4.10a: Hurzeler tunnelling instruments 
 
Figure 4.10b: Hurzeler tunnelling instruments 
 
Figure 4.10c: Hurzeler tunnelling instruments 
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For the control, the CTG was obtained from the palate. The trap-door technique was used. 
This involved making an ‘L’ shaped incision adjacent from the distal aspect of the canine up 
to the mesial root of the first molar depending on the length of tissue needed. The length of 
tissue was determined by the mesio-distal extent of the recession defect at the recipient 
site. A split thickness flap was raised and the subepithelial connective tissue was carefully 
dissected. This type of access flap allowed the donor site to be completely covered after the 
graft tissue was removed. An acrylic stent was placed in lieu of sutures (see figure 4.1). The 
stent exerted pressure onto the donor site aiding haemostasis and pain management. 
Patients were instructed to keep the acrylic plate in place continuously for five days. They 
were given a 0.2% chlorhexidine mouthwash to aid plaque control instead of conventional 
oral hygiene measures which would be difficult to carry out while wearing the acrylic plate.  
The CTG was trimmed as necessary and transferred to the recipient site and carefully placed 
and threaded into the gingival tunnel created. The flap was secured with Seralon® 
monofilament 4/0 DS 18 sutures using the double-crossed suture technique described by 
Zuhr and Hürzeler and Zuhr et al.122, 123 Prior to surgery, composites rests were created on 
the interproximal contact points. The enamel surface was etched for 10 seconds and 
bonded. 3M flowable composite was used and a probe was placed in a bucco-palatal 
direction on the composite surface while light curing. This created a groove which provided 
a fulcrum to help advance the flap coronally and support the graft.  
 
Figure 4.11: Seralon® suture 
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The needle was guided through the buccal soft tissue about 5mm apical to the tip of the 
papilla. The needle was pushed through to emerge at the base of the palatal papilla (figure 
4.12a). The needle was then looped around the composite rest and slid underneath the 
contact point to reappear at the palatal side (figure 4.12b). The procedure was repeated 
starting from the palatal side. The needle was guided from the palatal side to emerge at the 
base of the buccal papilla and then looped around the composite rest and slid underneath 
the contact point to re-emerge on the buccal side (figure 4.12c). The suture was closed and 
knotted on the buccal side (figures 4.12d and 4.12e).122  
 
Figure 4.12a122 
 
Figure 4.12b122 
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Figure 4.12c122 
 
Figure 4.12d122 
 
Figure 4.12e122 
This suture technique offers the following advantages:  
 It creates a coronal anchor point allowing for maximum coronal flap mobilisation and 
stabilisation while exerting gentle pressure.123  
 Crossing the suture over ensures wound stabilisation and improved flap and graft 
adaptation. This close tissue and flap adaptation increases revascularisation of the 
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graft tissue improving healing. It also encourages a thin blood clot to form which 
improves tensile strength and stability of the wound.123  
 Since the suture passes through the papilla twice, the knot tension is distributed 
more equally sparing the fragile buccal soft tissue.123  
 
The test site received the PRF membrane. Choukroun’s A-PRF preparation protocol was 
used. Just prior to surgery, intravenous blood was collected from the antecubital fossa in 10 
ml A-PRF+ blood vials and immediately centrifuged at 1500 rpm for eight minutes. At least 
two vials (always an even number) were filled equally for each patient. The vials were 
placed directly across from each other to ensure balance in the centrifuge.  
 
Figure 4.13: PC-O2 centrifuge used to create A-PRF (Process, Nice, France) 
The resultant fibrin clot was removed and compressed into a membrane using a PRF metal 
fabrication box.124 The compressed membrane was placed at the recipient site and sutured 
in the same way as the control site. 
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Figure 4.14: Separated blood components immediately after centrifugation 
 
Figure 4.15: PRF clot removed from glass vial 
 
Figure 4.16: PRF clot placed in PRF membrane fabrication box 
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Figure 4.17: Compression plate placed on PRF clot 
 
Figure 4.18: PRF box was closed and left until the membrane was needed 
 
Figure 4.19: The PRF clot was compressed into a membrane 
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Figure 4.20: PRF membrane 
 
4.11 Post-surgical protocol 
Patients were prescribed analgesics: paracetamol 500mg and ibuprofen 200mg, and a 0.2% 
chlorhexidine gluconate mouthwash. The ibuprofen was prescribed for three days 
postoperatively and the paracetamol prescribed for five days.  
Patients were instructed to avoid brushing the surgical site for two weeks, the chlorhexidine 
provided the necessary plaque control measures.  
At the two week recall appointment, sutures were removed, healing was assessed and 
plaque control measures were carried out. Oral hygiene instructions were reinforced and a 
modified brushing technique was explained to patients.  
Recall appointments were set up for 8, 12, 16 and 24 weeks postoperatively. At the 8, 12 
and 16 week appointments, all clinical parameters except for GT were recorded. GT was not 
measured at these appointments as I did not want to interrupt new gingival attachment by 
probing into the gingiva with a sharp endodontic reamer. Plaque control measures were 
carried out. An added advantage of a strict postoperative follow-up schedule such as this 
encourages long-term patient compliance and maintenance.3  
At the 24 week recall appointment, all clinical variables were measured, photographs were 
taken and patients completed a written questionnaire. 
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Figure 4.21: Pre-operative photograph of the E6 and E7 control site (tooth 45 and 44 
respectively) 
 
Figure 4.22: Postoperative photograph of the E6 and E7 control site (tooth 45 and 44 
respectively) 
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Figure 4.23: Pre-operative photograph of the E6 and E7 test site (tooth 35 and 34 
respectively) 
 
Figure 4.24: Postoperative photograph of the E6 and E7 test site (tooth 35 and 34 
respectively) 
4.12 Ethical considerations 
Ethical clearance was applied to and approved by the Human Research Ethics Committee 
(HREC). Certificate no M150506 (appendix 6). As per the requirements of the HREC, 
investigators completed Investigator Training Programs for Good Clinical Practise    
(appendix 7). 
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CHAPTER 5 
5 RESULTS  
Table 5.1: Patient demographic information. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The sample population consisted of six patients, three males and three females aged 
between 29 and 69 years (mean age was 48.67). Patients were enrolled and surgical 
treatments completed between January and June 2016. Patients were seen for a total of 
five recall appointments (at 2, 8, 12, 16 and 24 weeks) over six months and the 
observational period concluded in December 2016. One patient (patient D) failed to comply 
with the recall appointments and was therefore disqualified from the study but was 
included in this report for statistical purposes.  
Patient Demographics 
Patient Pair Age Gender Tooth 
Control 
(C) or Test 
(T) 
A A1 69 M 13 C 
    23 T 
B B2 66 M 23 C 
    13 T 
C C3 29 F 14 C 
    24 T 
D D4 40 F 35 C 
    45 T 
E E5 41 F 14 C 
    24 T 
E E6 41 F 45 C 
    35 T 
E E7 41 F 44 C 
    34 T 
F F8 47 M 15 C 
    45 T 
F F9 47 M 14 C 
    24 T 
F F10 47 M 13 C 
    23 T 
F F11 47 M 34 C 
    44 T 
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Five patients with a collective total of twenty sites (i.e. ten paired sites) completed the 
study. Three patients (patients A, B and C) presented with two recession sites each (i.e. one 
paired site), one patient (patient E) presented with six recession sites (i.e. three paired sites) 
and one patient (patient F) presented with eight recession sites (i.e. four paired sites).  
In patients E and F, sites on different quadrants were paired. Each set of paired sites were 
treated as a single pair and labelled according to patient and site number i.e. E5, E6, E7, F8, 
F9, F10 and F11.   
Six of the twenty sites were located at upper canines, while recessions at the remaining 
fourteen sites were spread between the upper and lower premolars. The most commonly 
treated premolar was the upper first premolars with six sites, seven sites were distributed 
between the lower first and second premolars and one upper second premolar was treated.  
For each site, the following six clinical parameters were recorded in millimetres (mm), see 
appendices 8-13: 
Table 5.2: Clinical parameters 
Clinical Parameters Mesio-buccal (MB) Buccal (B) Disto-buccal (DB) 
PD (periodontal probing depth)* MB B DB 
RD (recession depth)* MB B DB 
CAL (clinical attachment level)* MB B DB 
RW (recession width)** 
RW was measured using a UNC 15 probe at the widest 
horizontal distance from the mesial to the distal margins 
of the recession defect  
KTW (keratinised tissue width)** KTW was measured using a UNC 15 probe along the 
vertical mid-buccal groove of the measuring guide. 
GT (gingival thickness)** 
GT was recorded using rubber stoppers at the end of 
endodontic reamers at the point corresponding to the 
vertical line of the mid-buccal groove of the measuring 
guide and the mid-point of the width of keratinised 
gingiva. 
* Variables measured at three points 
** Variables measured at one point 
The Pink Esthetic Score (PES) was calculated for each site before treatment and again at 24 
weeks (appendix 14). Patient perception responses were tabulated in Appendix 15. For each 
patient, the clinical measurements, PES and patient questionnaire responses were 
summarised and are presented and discussed in this chapter.  
 67 
 
Each patient was a unit of analysis. In patients with multiple paired sites (patients E and F), 
the mean of the each variable will be used for statistical analysis. Success of recession 
treatment is considered to be any decrease in the amount of exposed root surface.70 Hence, 
while all variables are discussed, the primary variables that were analysed to determine root 
coverage was RD and RW. 
The sample size was not large enough to prove whether there was a variance in the rate of 
improvement between the individual points of measure; namely (MB, B and DB). Therefore, 
an assumption was made that the rate of improvement or lack thereof was the same 
between the three points and the mean was used for analysis.  
Statistical analysis was done to compare the baseline values to the 24 week values for each 
single paired patient (A to C); and for those patients with multiple paired sites (E and F), the 
patient’s mean values were analysed as a group. This model is similar to Hirsch et al. 
wherein each patient was a unit of analysis and when more than one site was treated in a 
patient, the patient mean values were analysed.125 
With regards to the patient questionnaire, the data was summarised and analysed for each 
patient. The patient questionnaire was based on a Likert scale.120 A Likert scale assumes that 
the power of experience is linear i.e. a patients satisfaction or dissatisfaction can be 
measured.121 As the data was ordinal, it was summarised as a mode in patients with 
multiple sites. 
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5.1 Patient A  
 Observation and Results  
At the 2 week appointment, patient A reported intense pain at the palatal donor site during 
the first ten days. The pain gradually subsided between days eleven and fourteen. The 
patient also reported that the sutures at the test site loosened and some tissue was lost. 
Table 5.3: Tabulation of clinical results for pair A1 
    Control Test 
PD 0 weeks 2 2 24 weeks 2 2 
RD 0 weeks 3,67 2,67 24 weeks 2,33 2,33 
RW 0 weeks 7 7 24 weeks 6 6 
CAL 0 weeks 5,67 4,67 24 weeks 4,33 4,33 
KTW 0 weeks 2 2 24 weeks 2 2 
GT 0 weeks 1 0,5 24 weeks 1,5 1 
PES 
0 weeks 11 10 
24 weeks 12 12 
Abbreviation key: PD= probing depth, RD= recession depth, RW- recession width, CAL= clinical attachment 
level, KTW= keratinised tissue width, GT= gingival thickness, PES= pink esthetic score. 
 Data Summary and analysis 
There was root coverage (yes) at both sites.  At the control site, there was a 36.5% reduction 
in mean RD from 3,67mm to 2,33mm. At the test site, mean RD decreased from 2,67mm to 
2,33mm; a 12.8% improvement. While the final result at both sites is the same, the control 
site showed greater reduction in RD. Both sites displayed identical improvements in RW 
from 7mm to 6mm. CAL also improved at both sites but was greater at the control with 
23.6% improvement (from 5,67mm to 4,33mm) and only a 7.3% improvement at the test 
site. The mean PD measurements remained unchanged at baseline and 24 weeks at both 
the control and test site.  KTW remained unchanged (2mm) at both sites. 
Overall, the control site showed greater improvement in recession measurements than the 
test site. GT improved at both sites. At the control site, GT changed from 1mm to 1.5mm 
(50% improvement) and 0.5mm to 1mm (100% improvement) at the test site. The PES 
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improved at both sites. At the control site there was a 1 point improvement and a 2 point 
improvement at the test site. 
 Summary of Patient Perceptions 
The patient scored both sites the same. He scored dentine sensitivity with ‘slight 
improvement’ while there was ‘no change’ in all other soft tissue variables.  
Table 5.4: Tabulation of scores from patient questionnaire 
 
 
 
The scores are based on the Likert key tabulated on a 5 point scale: 1= much worse than before, 2= slightly 
worse than before, 3= no change, 4= slight improvement, 5= noticeable improvement. 
 
5.2 Patient B 
 Observations and Results 
As a point of interest, patient B was diabetic and his disease was well-controlled. Diabetes 
was neither included nor excluded from the study cohort by design and as such patients B’s 
diabetic status was not a limiting factor. 
At the 2 week recall appointment, patient B said that the palatal wound reportedly bled for 
one and a half days. His face was swollen on both sides for three days postoperatively and 
pain was felt at all three surgical sites. The most intense pain was felt at the donor palatal 
site. In this patient, the acrylic stent did not fit as well as on the other patients and it was 
slightly loose. This reduction in pressure against the palate could be the reason for the 
extended bleeding time and pain. Postoperative swelling is expected after surgery as the 
gingival tissues and blood vessels are sharply dissected when creating the tunnel flap.113 This 
was managed with anti-inflammatory drugs. Pain at the test site resolved fairly quickly but 
pain at the control site was still felt at 2 weeks postoperatively. He recounted that the distal 
suture at the control site loosened after a few days and subsequently some tissue was lost. 
He also reported that there was loss of sensation at the palatal donor site. At subsequent 
  
Level of 
Gingival 
Recession 
Dentine 
Sensitivity 
Gingival  
Colour 
Gingival 
Shape 
Control  3 4 3 3 
Test 3 4 3 3 
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appointments, this was evaluated and some sensation began to return at the 8 week recall 
appointment and sensation was back to normal at 24 weeks.  
Table 5.5: Tabulation of results for pair B2 
    Control Test 
PD 0 weeks 2 3,33 24 weeks 2 3 
RD 0 weeks 2,67 3 24 weeks 1,33 1,33 
RW 0 weeks 5 5 24 weeks 4 4 
CAL 
0 weeks 4,67 6,33 
24 weeks 3,33 4,33 
KTW 0 weeks 3 4 24 weeks 2 5 
GT 
0 weeks 0,5 1,5 
24 weeks 1 1 
PES 0 weeks 8 11 24 weeks 8 12 
Abbreviation key: PD= probing depth, RD= recession depth, RW- recession width, CAL= clinical attachment 
level, KTW= keratinised tissue width, GT= gingival thickness, PES= pink esthetic score. 
 Data Summary and analysis 
There was root coverage (yes) at both sites. Mean RD improved at both sites, 50.19% at the 
control site and 55.67% at the test site. Although there were mean RD improvements at 
both sites, the test site demonstrated a 5.48% greater improvement over the control site. 
Both sites displayed identical improvements in RW from 5mm to 4mm. CAL also improved at 
both sites but was greater at the test site with 31.9% improvement (from 6,33mm to 
4,33mm) and 28.7% improvement at the control site. 
The mean PD at the control site remained unchanged over the study period, while at the 
test site it reduced by 10% (from 3,33mm to 3mm). KTW decreased at the control site, from 
3mm at baseline to 2mm at 24 weeks while at the test site, KTW increased from 4mm to 
5mm over this period. GT improved by 0.5mm (from 0,5mm to 1mm) at the control site but 
decreased by 0.5mm (from 1,5mm to 1mm) at the test site.  
At the control site, the PES score remained unchanged at 8 points. At the test site, the score 
improved from 11 to 12 points over the study period.  
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 Summary of Patient Perceptions 
The patient scored both sites the same. He scored the level of gingival recession as ‘slight 
improvement’. There was a ‘noticeable improvement’ in gingival colour. Dentine sensitivity 
and gingival shape were both scored as ‘no change’.  
Table 5.6: Tabulation of scores from patient questionnaire 
 
 
 
 
The scores are based on the Likert key tabulated on a 5 point scale: 1= much worse than before, 2= slightly 
worse than before, 3= no change, 4= slight improvement, 5= noticeable improvement. 
 
5.3 Patient C 
 Observations and Results 
During the surgical appointment, there was some difficulty in isolating the cubital veins of 
patient C. Eventually, we managed to collect two vials of blood and this was sufficient in this 
patient because there was only one site to treat with PRF.  
At the 2 week recall appointment, patient C reported that she experienced severe pain at 
the palatal donor site. She needed to take analgesics for longer than the prescribed period.  
The pain subsided 1 week postoperatively. 
  
  
Level of 
Gingival 
Recession 
Dentine 
Sensitivity 
Gingival  
Colour 
Gingival 
Shape 
Control  4 3 5 3 
Test 4 3 5 3 
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Table 5.7: Tabulation of results for pair C3 
   Control Test 
PD 0 weeks 2 2 24 weeks 2 2,33 
RD 0 weeks 0,67 0,67 24 weeks 0,33 0,67 
RW 
0 weeks 3 4 
24 weeks 0 3 
CAL 0 weeks 2,67 2,67 24 weeks 2,33 3 
KTW 
0 weeks 4 4 
24 weeks 6 6 
GT 0 weeks 1 1 24 weeks 1,5 1 
PES 0 weeks 14 14 
24 weeks 13 14 
Abbreviation key: PD= probing depth, RD= recession depth, RW- recession width, CAL= clinical attachment 
level, KTW= keratinised tissue width, GT= gingival thickness, PES= pink esthetic score. 
 Data Summary and Analysis 
There was root coverage (yes) at the control site but no root coverage at the test site.  
At the control site, there was a 50.75% reduction in mean RD from 0,67mm to 0,33mm over 
the study period. At the test site, mean RD remained unchanged at 0,67mm. RW reduced a 
100% at the control site while there was only a 25% improvement (from 4mm to 3mm) at 
the test site. CAL improved by 12.3% (from 2,67mm to 2,33mm) at the control site and 
worsened by 12.36% (from 2,67mm to 3mm). Both sites displayed identical improvements 
in KTW from 4mm to 6mm.  Mean PD at the control site remained unchanged over the 
study period (at 2mm) while at the test site, mean PD worsened from 2mm to 2,33mm over 
the same period. GT increased by 50% (from 1mm to 1,5mm) at the control site with no 
change at the test site. Overall the control site demonstrated superior results than the test 
site.  
The PES score decreased by 1 point at the control site. There was slight change to the 
natural soft tissue contour with loss of some gingival scalloping, hence the decrease. It was 
so minor that the patient did not notice it and scored the gingival shape as ‘no change’ on 
the questionnaire (see table 5.8). The test site remained a perfect score of 14. In patient C, 
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the baseline aesthetic scores was already high and neither treatment worsened the 
aesthetic result significantly.  
On the questionnaire, the only change the patient noted was that dentine sensitivity at the 
control site had ‘noticeably improved’. She commented that the sensitivity at this site 
resolved completely while the test site was still sensitive. As her motivation for the 
treatment was to improve dentine sensitivity, she was interested in undergoing further 
treatment at the test site to improve sensitivity at this site and she wanted the same 
treatment that was done at the controls site i.e. CTG. She was happy with the aesthetic 
result.  
 Summary of Patient Perceptions 
The patient scored all sites as ‘no change’ except for dentine sensitivity at the control site. 
This was scored with a ‘noticeable improvement’. 
Table 5.8: Tabulation of scores from patient questionnaire 
 
 
 
 
The scores are based on the Likert key tabulated on a 5 point scale: 1= much worse than before, 2= slightly 
worse than before, 3= no change, 4= slight improvement, 5= noticeable improvement. 
  
  
Level of 
Gingival 
Recession 
Dentine 
Sensitivity 
Gingival  
Colour 
Gingival 
Shape 
Control  3 5 3 3 
Test 3 3 3 3 
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5.4 Patient D 
 Observations and results 
At the 2 week appointment, the patient reported that the test site was very swollen for a 
few days after the surgery. The control site healed uneventfully.  
Patient D was seen until the 8 week recall appointment. She then failed to comply with any 
of the subsequent appointments and was disqualified from the study. The measurements 
recorded at baseline and 8 weeks are tabulated below to complete data summary.   
Table 5.9: Tabulation of results for patient D at the control site 
    Control Test 
PD 
0 
weeks 1 1,33 
8 
weeks 1,33 1,67 
RD 
0 
weeks 1,67 1,33 
8 
weeks 0,33 1,33 
RW 
0 
weeks 4 5 
8 
weeks 3 4 
CAL 
0 
weeks 2,67 2,67 
8 
weeks 1,67 3 
KTW 
0 
weeks 0,5 0,5 
8 
weeks 1 1 
GT 
0 
weeks 0,5 0,5 
8 
weeks 
Gt measured at 24 
weeks 
PES 
0 
weeks 14 14 
8 
weeks 
Photographs not 
taken  
Abbreviation key: PD= probing depth, RD= recession depth, RW- recession width, CAL= clinical attachment 
level, KTW= keratinised tissue width, GT= gingival thickness, PES= pink esthetic score. 
 
 75 
 
 
5.5 Patient E 
 Observation and Results 
Patient E was treated at six sites. She was able to remove the palatal stent after three days, 
as the pain at the palatal site had subsided. At the 8 week appointment, she reported 
numbness at the palatal donor site. There was some sensation when the site was stroked 
with a probe validating the perception, and full sensation returned by week 24. 
Since there were multiple sites for patient E (and F), the data collected and statistics derived 
are more comprehensive than in the previous patients. Specifically, data was collected for 
all sites and there were two types of mean calculations determined as presented in the 
tables below. The mean in the top row (headings) is the mean of the MB, B and DB 
measurements per site. The mean in column 1 (second last row) is the mean of the pairs 
(E5, E6 and E7). Further, the control and test data was separated into their own tables as 
presented below. 
Table 5.10: Tabulation of results for patient E at the control site 
Abbreviation key: PD= probing depth, RD= recession depth, RW- recession width, CAL= clinical attachment 
level, KTW= keratinised tissue width, GT= gingival thickness, PES= pink esthetic score. 
Table 5.11: Tabulation of results for patient E at the test site 
Abbreviation key: PD= probing depth, RD= recession depth, RW- recession width, CAL= clinical attachment 
level, KTW= keratinised tissue width, GT= gingival thickness, PES= pink esthetic score. 
  
  Mean PD Mean RD RW Mean CAL KTW GT PES 
Weeks 0 24 0 24 0 24 0 24 0 24 0 24 0 24 
Pair E5 2,00 2,00 1,33 1,33 4,00 4,00 3,33 3,33 4,00 1,00 1,00 1,00 11,00 12,00 
Pair E6 2,00 2,33 1,33 2,33 3,00 3,00 3,33 4,67 2,00 3,00 1,5 1,5 14,00 14,00 
Pair E7 2,33 1,67 1,33 1,00 3,00 3,00 3,67 2,67 1,00 1,00 0,5 0,5 14,00 14,00 
Mean  2,11 2,00 1,33 1,55 3,33 3,33 3,44 3,56 2,33 1,67 1,00 1,00 13,00 13,33 
STD Dev  0,19 0,33 0,00 0,69 0,58 0,58 0,20 1,02 1,53 1,15 0,50 0,50 1,73 1,15 
  Mean PD Mean RD RW Mean CAL KTW GT PES 
Weeks 0 24 0 24 0 24 0 24 0 24 0 24 0 24 
Pair E5 1,67 2,00 1,00 0,67 3,00 3,00 2,67 2,67 3,00 5,00 1,00 1,00 14,00 14,00 
Pair E6 2,33 2,00 1,67 1,33 4,00 4,00 3,67 3,33 2,00 2,00 1,00 1,00 14,00 14,00 
Pair E7 2,00 2,00 1,33 1,33 4,00 3,00 3,33 3,33 2,00 2,00 1,00 1,00 14,00 14,00 
Mean  2,00 2,00 1,33 1,11 3,67 3,33 3,22 3,11 2,33 3,00 1,00 1,00 14,00 14,00 
STD Dev 0,33 0,00 0,34 0,38 0,58 0,58 0,51 0,38 0,58 1,73 0,00 0,00 0,00 0,00 
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 Data Summary and analysis 
There was root coverage (yes) at one of the three control sites (E7) and two of the three test 
sites (E5 and E6). 
The summary statistics show that in the control group, the mean baseline RD measurement 
was 1.33mm ±0.00mm and at 24 weeks the mean RD measurement was 1.55 ±0.69mm. In 
the test group, the mean baseline RD measurements were 1.33 ±0.34mm and 1.11 
±0.38mm at 24 weeks. The control group was on average 16% worse while the test group 
was 16.54% better. By virtue of the resultant standard deviations for the two groups, it 
appears that the test result is more consistent. There was no change in mean RW of the 
control group while there was a 9% improvement in mean RW in the test group. CAL 
worsened slightly (3.4%) in the control group and improved slightly (3.4%) in the test group.  
KTW worsened in the control group by 28.3% while it improved in the test group by 28.76%. 
Overall, in patient E, PRF demonstrated better results than CTG. 
Table 5.12: Tabulation of descriptive statistics and t-test results for patient E  
 
Descriptive statistics and t-tests revealed that while the improvement for both control and 
test was the same, i.e. the high p-value indicates that the null hypothesis is supported (table 
5.12), skewness and kurtosis could only be calculated for the RD and CAL distributions. 
However, these distributions differed in that the control favoured negatively scored 
distributions while the test positively scored.  This supports that the test sample variance 
results were slightly lower if not similar and the mean is lower than the hypothesised mean. 
t-Tests cannot be reliably used for the RW, KTW and GT since Microsoft Excel returned 
undefined (divide by zero) scores for the distributions. These are noted as “U” in the table. 
The PES increased in the CTG group from a baseline mean of 13.00 ±1.73 to 13.33 ±1.15. In 
the PRF group, the PES remained unchanged at perfect score of 14.  
  
RD CAL RW KTW GT 
 
Patient E 
P(T<=t) two-tail 0,35 0,71 0,42 0,55 N/A 
Kurtosis -0,01 0,73 -1,25 1,13 U U U U U U 
Skewness -0,50 1,62 -0,68 0,02 U 1,73 1,29 -1,73 U U 
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According to the patient questionnaire, patient E scored the test sites has having improved 
over the control site. She stated that dentine sensitivity and the gingival margin improved at 
the test sites while these same variables worsened slightly at the control sites.  
 Summary of Patient Perceptions  
Patient E scored the level of gingival recession and dentine sensitivity at the test sites as 
improved while the control sites worsened. The variables gingival colour and shape 
remained unchanged at all sites. This perception correlates to the clinical results as the test 
group demonstrated improvements in RD while the control group worsened. RW decreased 
in the test group and remained unchanged in the control group. Further, the PES remained 
unchanged or improved (control site E5) correlating to the patients perception of “no 
change” in terms of gingival colour and shape.  
Table 5.13: Tabulation of scores from patient questionnaire 
The scores are based on the Likert key tabulated on a 5 point scale: 1= much worse than before, 2= slightly 
worse than before, 3= no change, 4= slight improvement, 5= noticeable improvement. 
 
 
  
Pair 
Level of Gingival 
Recession Dentine Sensitivity Gingival  Colour Gingival Shape 
  Control Test Control Test Control Test Control Test 
E5 2 4 2 5 3 3 3 3 
E6 2 4 2 5 3 3 3 3 
E7 2 4 2 5 3 3 3 3 
Mode 2 4 2 5 3 3 3 3 
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5.6 Patient F 
 Observation and results 
At the 2 week recall appointment, patient F reported that he was experiencing severe pain 
in the upper right quadrant. On examination, the 23 and 24 area (test sites) was inflamed 
and there was gingival sloughing in the area. The other surgical sites had satisfactory 
healing. At subsequent appointments, healing at the sites 23 and 24 improved (without 
additional treatment). 
Table 5.14: Tabulation of results for patient F at the control site 
Abbreviation key: PD= probing depth, RD= recession depth, RW- recession width, CAL= clinical attachment 
level, KTW= keratinised tissue width, GT= gingival thickness, PES= pink esthetic score. 
Table 5.15: Tabulation of results for patient F at the test site 
Abbreviation key: PD= probing depth, RD= recession depth, RW- recession width, CAL= clinical attachment 
level, KTW= keratinised tissue width, GT= gingival thickness, PES= pink esthetic score. 
 Data Summary and analysis 
Two of the four control sites showed root coverage (yes) and one of the four test sites had 
root coverage.  
The summary statistics show that in the control group, mean baseline RD measurement was 
1.84mm ±0.88mm and at 24 weeks the mean RD measurement was 1.75 ±0.50mm. In the 
  Mean PD Mean RD RW Mean CAL KTW GT PES 
Weeks 0 24 0 24 0 24 0 24 0 24 0 24 0 24 
Pair F8 2,00 2,00 1,67 1,33 5,00 5,00 3,67 3,33 4,00 4,00 1,00 2,00 8,00 11,00 
Pair F9 1,67 2,00 2,33 2,33 5,00 5,00 4,00 4,33 3,00 4,00 1,5 2,00 10,00 10,00 
Pair F10 2,00 2,67 0,67 1,33 4,00 5,00 2,67 4,00 4,00 4,00 1,00 1,5 10,00 10,00 
Pair F11 2,00 2,67 2,67 2,00 5,00 5,00 4,67 4,67 3,00 1,00 1,00 1,00 11,00 13,00 
Mean 1,92 2,34 1,84 1,75 4,75 5,00 3,75 4,08 3,50 3,25 1,13 1,63 9,75 11,00 
STD dev  0,17 0,39 0,88 0,50 0,50 0,00 0,83 0,57 0,58 1,50 0,25 0,48 1,26 1,41 
  Mean PD Mean RD RW Mean CAL KTW GT PES 
Weeks 0 24 0 24 0 24 0 24 0 24 0 24 0 24 
Pair F8 1,67 2,33 1,67 1,00 4,00 5,00 3,33 3,33 2,00 2,00 0,5 1,00 11,00 11,00 
Pair F9 1,67 2,00 1,33 1,33 5,00 5,00 3,00 3,33 6,00 5,00 1,5 2,00 9,00 10,00 
Pair F10 2,00 4,67 1,67 2,00 6,00 6,00 3,67 6,67 4,00 3,00 1,00 1,00 11,00 10,00 
Pair F11 2,00 2,33 1,00 1,33 4,00 4,00 3,00 3,67 3,00 3,00 1,00 1,00 12,00 13,00 
Mean 1,84 2,83 1,42 1,42 4,75 5,00 3,25 4,25 3,75 3,25 1,00 1,25 10,75 11,00 
STD dev 0,19 1,23 0,32 0,42 0,96 0,82 0,32 1,62 1,71 1,26 0,41 0,50 1,26 1,41 
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test group, mean baseline RD measurement was 1.42mm ±0.32mm and at 24 weeks the 
mean RD measurement was 1.42 ±0.42mm.  
Table 5.16 Tabulation of descriptive statistics and t-test results for patient F 
 
Descriptive statistics and t-tests revealed that while the improvement for both control and 
test was the same, i.e. the high p-value indicates that the null hypothesis is supported (table 
5.16), skewness and kurtosis could only be reliably used for the RD and CAL distributions. 
The RD and CAL distributions exhibited similar scores.  This supports the use of the findings. 
However, t-Tests cannot be reliably used for the RW, KTW and GT the score for the other 
three measures were fairly extreme. 
In the control group, mean baseline RW measurement was 4.75mm ±0.50mm and at 24 
weeks the mean RW measurement was 5.00 ±0.00mm. In the test group, mean baseline RW 
measurement was 4.75mm ±0.96mm and at 24 weeks the mean RW measurement was 5.00 
±0.82mm. RW worsened in both groups.  
In the control group, mean baseline CAL measurement was 3.75mm ±0.83mm and at 24 
weeks the mean CAL measurement was 4.08 ±0.57mm. In the test group, mean baseline 
CAL measurement was 3.25mm ±0.32mm and at 24 weeks the mean RW measurement was 
4.25 ±1.62mm. CAL worsened in both groups.  
Mean GT and PES improved in both sites. 
  
  
RD CAL RW KTW GT 
 
Patient F 
P(T<=t) two-tail 0,79 0,12 1,00 0,79 0,18 
Kurtosis -0,19 -0,86 -0,25 -1,28 4,00 4,00 2,23 -6,00 1,50 -6,00 
Skewness -0,09 0,00 -0,14 -0,46 -2,00 -2,00 1,13 0,00 0,00 0,00 
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 Summary of Patient Perceptions 
The patient scored all control and test sites as “noticeable improvement”. 
Table 5.17: Tabulation of scores from patient questionnaire 
The scores are based on the Likert key tabulated on a 5 point scale: 1= much worse than before, 2= slightly 
worse than before, 3= no change, 4= slight improvement, 5= noticeable improvement. 
 
 
 
 
Pair 
Level of Gingival 
Recession Dentine Sensitivity Gingival  Colour Gingival Shape 
  Control Test Control Test Control Test Control Test 
F8 5 5 5 5 5 5 5 5 
F9 5 5 5 5 5 5 5 5 
F10 5 5 5 5 5 5 5 5 
F11 5 5 5 5 5 5 5 5 
Mode 5 5 5 5 5 5 5 5 
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CHAPTER 6 
6 DISCUSSION 
The purpose of this study was to evaluate and compare the clinical outcomes of CTGs and 
PRF in treating gingival recession. The study set out to: 1) Determine the clinical efficacy of 
PRF membranes, 2) Compare the clinical and aesthetic outcomes between the two groups 
and 3) Determine patient aesthetic satisfaction between the two groups.  
6.1 Clinical Outcomes 
As discussed in chapter 4.9 Data Analysis, this study is an extended case series and 
therefore, each patient was a unit of analysis and was analysed independently of each 
other.125 There were three patients with single paired sites (A1, B2 and C3) while two 
patients had multiple paired sites. Patient E had three paired sites (E5, E6 and E7) and 
patient F had four paired sites (F8, F9, F10 and F11). Patient D4 was excluded from data 
analysis as she failed to comply with the study’s requirements.   
The primary variables analysed to determine clinical improvements in root coverage were 
RD and RW. Keratinised tissue changes (KTW and GT) were secondary outcomes.  
With regards to the recession measurements, there were improvements at both CTG and 
PRF sites but there were a greater number of CTG sites which showed improvements. Of the 
total sites treated, six of the ten control sites and only five of the ten test sites 
demonstrated root coverage. In the single paired sites A1 and C3, the control sites showed 
greater improvements in RD measurements than the test sites while test site B2 showed a 
greater improvement than its corresponding control site. In patients A1, B2 and C3, RW 
improved at all control and test sites. RW changes between the control and test sites for A1 
and B2 were the same. However, control site C3 showed a 100% improvement while test 
site C3 showed a less favourable 25% improvement. Overall in the single paired sites, CTG 
performed better with only one PRF site (B2) performing better than its control. At the 2 
week recall appointment, patient B reported that some tissue was lost from the CTG site. 
The poorer result at this CTG site (B2) could be due to loss of some graft tissue and 
therefore a compromised outcome at this particular CTG site.  
 82 
 
 
CAL (recorded as a loss) decreased at all single paired sites. In patient A1, the control site 
performed better with a 24% improvement whereas the test site had only a 7% 
improvement.  In patients B2 and C3, the control and test sites showed similar decreases in 
CAL (B2: 29% at the control and 32% at the test site, C3: 12% at the control and 13% at the 
test site). This demonstrates that both CTGs and PRF have the potential to improve CALs. 
In patients E and F, descriptive statistics and t-tests revealed that the improvement for both 
control and test was the same, i.e. the high p-value indicates that the null hypothesis is 
supported. In patient E, the individual test sites displayed slightly better results in RD and 
CAL than the control sites (the test sample variance results were slightly lower if not similar 
and the mean was lower than the hypothesised mean). These results in patients E and F are 
mirrored in a similarly designed study by Jankovic et al. where CTGs was compared to 
PRF.102 It was found that RD improved in both groups with no statistical difference between 
groups.102 In patients E and F, RW measurements remained unchanged at most sites (11 of 
the 14 sites). Of the three sites that demonstrated a change in RW, only one site improved 
(test site E7 improved by 1mm). The other two sites worsened by 1mm each (test site F8 
and control site F10). It was not possible to test statistical significance of RW in patients E 
and F as Microsoft Excel 2016 returned undefined (divide by zero) scores for the 
distributions. These results in clinical measurements demonstrates that both CTGs and PRF 
have the potential to reduce recession measurements.   
There were improvements in GT at many sites, 60% of CTG sites demonstrated an increase 
in GT while only 30% of the PRF sites increased in GT. CTGs showed a greater inclination to 
increase GT than PRF. Few studies report on changes in GT. While reviewing the literature, I 
found only two studies that reported on changes in GT. Both studies also used a 6 month 
observation period and GT was recorded at baseline and 6 months. One of the studies was 
conducted by Eren and Atilla, wherein CTGs and PRF in combination with a CAF was also 
evaluated and compared.12 The authors found similar statistically significant improvements 
in GT measurements in both groups.12 The present study, on the other hand, showed a 
greater increase at the CTG sites.  The second study; by Aroca et al. tested a CAF alone to a 
CAF combined with PRF and found statistically significant improvements in GT in the PRF 
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group.11 These results demonstrate that PRF in combination with a CAF can be more 
beneficial than using a CAF alone in treating gingival recession.  
The present study’s results demonstrates that CTGs provide greater improvements in GT 
over PRF. The increase in GT at the CTG sites can be explained by the influence of the type 
of connective tissue used. Connective tissue from the palate contains the biological signals 
that induce the overlying epithelium to differentiate into keratinised epithelium.12, 56, 80, 82 In 
a study by Zucchelli et al. where de-epithelised CTGs were compared to epithelised CTGs, it 
was found that GT increased in patients with de-epithelised CTGs.126 The present study also 
used de-epithelised palatal CTGs. The increase in the PRF group may be explained by the 
influences of the growth factors trapped within the PRF membrane.12 These growth factors 
positively influence proliferation and differentiation of the gingival and periodontal ligament 
fibroblasts and epithelial cells encouraging angiogenesis.102 The dense 3-dimensional fibrin 
structure of PRF may also function in a similar fashion to an extracellular matrix by providing 
stability to the wound and acts as a scaffold for cellular interactions thereby increasing the 
thickness of the overlying epithelium.17 Previous studies have emphasised the benefits of 
increasing the amount of keratinised tissue. An increase in GT contributes to complete root 
coverage, long-term periodontal stability and helps prevent further gingival recession over 
time.102, 127 Therefore, increases in GT is a desired outcome of any surgical treatment. 
Although both CTGs and PRF demonstrated the potential to do so, CTGs performed better 
than PRF.  
The KTW results of this study showed improvements in only six of the twenty sites (three 
control and three test sites). There were decreases in KTW in three control sites and two 
test sites while the remaining sites stayed the same (four control sites and five test sites). In 
their CTG and PRF study, Jankovic et al. observed a different outcome over 6 months with 
statistical gain in KTW in both groups.102  
Overall, both CTGs and PRF can improve clinical outcomes in treating gingival recessions but 
CTGs demonstrated improved clinical outcomes at a greater number of sites.  These findings 
supports the view by many authors that CTGs with a CAF produces the best results in 
treating recessions.8, 11, 13, 112, 128, 129  
 84 
 
 
A clinical limitation of PRF is the phlebotomy component of its preparation. In some 
patients, (as in patient C in this study) it can be challenging to not only isolate the required 
veins but also in obtaining the required volume of blood. This can pose a limitation chair 
side and can make completing treatment difficult. Enhancing the localisation of subsurface 
veins may make obtaining blood easier. A Doppler ultrasound uses high-frequency sound 
waves to measure blood flow and can be used to identify the position of blood vessels.130 
However, this technique requires additional training and/or assistants with added expense. 
A simpler alternative may be devices that use non-invasive near-infrared light.130 In the 
wavelength of 700-900nm, haemoglobin and oxy-haemoglobin are the main absorbers of 
light.131 When this infra-red light is placed over skin, blood flowing in the area absorbs light 
in this wavelength spectrum causing blood vessels to appear much darker than the 
surrounding tissues.130 This type of device is economical and much easier to use than a 
Doppler ultrasound. There are home devices that use this technology to aid in the early 
detection of breast cancer. These devices are small, relatively inexpensive and are meant to 
be used easily and correctly by anyone.131 Hence it is a viable aid for isolating veins for 
easier blood withdrawal.  
6.2  Aesthetic Outcomes  
According to Chambrone et al. improved gingival aesthetics is considered the primary goal 
of root coverage procedures.132 Furthermore, Zucchelli et al. states that root coverage 
success should be determined not only by reductions in recession measurements but also by 
soft tissue coverage, the thickness and colour of which should be indistinguishable from 
those of adjacent soft tissue.44 
This study used the PES as an objective and reproducible aesthetic scoring system and 
demonstrated that both CTGs and PRF can improve aesthetic outcomes. In a comparative 
type study by Kerner et al., it was found that a before and after scoring system is an 
acceptable and reliable method for aesthetic assessment of root coverage treatment.108 
The aesthetic results in both groups were similar and no patient was dissatisfied with the 
aesthetic outcomes. Across the control and test groups, there were eight sites with an 
increased PES, ten sites with no change and two sites that decreased in the PES. The 
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increases in the PES were distributed equally between the control and test sites i.e. four 
control sites A1, E5, F8 and F11 while the four test sites were A1, B2, F9 and F11.  
The decreases in the PES were at control site C3 and test site F10. At both sites, there was a 
change from a perfect score of two (“natural”) on soft tissue contour to a “fairly natural” 
score of one. This change in tissue contour may be the result of the surgical incisions into 
the sulcus and not necessarily as a result of the graft or PRF membrane. The remaining sites 
displayed an improvement in the PES or an unchanged aesthetic score i.e. the aesthetic 
score did not worsen. Therefore, both CTGs and PRF have the potential to improve gingival 
aesthetics or at the very least maintain aesthetics at any given site.  
There are limited studies that have systematically evaluated aesthetic outcomes using any 
type of visual scoring system. Studies simply comment on aesthetic outcomes using either 
general terms such as ‘‘aesthetically pleasing’’ or ‘‘good aesthetic results’’, or a by using a 
scale similar to “good”, “regular” or “poor”.72, 106 In a study by Rosetti et al. aesthetic results 
were evaluated on a good, regular and poor scale. The authors recognised that this type of 
scoring system is dependent on a subjective clinical impression.106 Another study by 
Bouchard et al. used a scoring system of good, moderate and poor. They also acknowledged 
that this type of aesthetic evaluation was subjective and tried to eliminate this bias by using 
independent examiners to evaluate the aesthetic outcomes.133 These methods of scoring 
aesthetics is not ideal as it is not only subjective but also not reproducible.  In contrast, the 
present study is unique in that I used a more objective means to evaluate aesthetics. The 
PES is a reproducible, reliable and predictable scoring system which evaluates seven specific 
characteristics of gingival tissue to calculate a maximum score of fourteen.107 Studies which 
evaluated aesthetic results pre-date aesthetic scoring systems and therefore the results of 
this study cannot be compared to any other studies. 
6.3 Patient-Based Outcomes  
According to Bouchard et al. the success of root coverage procedures should be determined 
by the patient and not the clinician.72 The ultimate goal of any treatment is patient 
satisfaction. To this aim, patients were given a questionnaire to score treatment outcomes 
on a Likert type scale (appendix 4). The questionnaire was given to patients at the end of the 
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study period. Patients were asked to score four features of each site: marginal gingival level, 
dentine sensitivity, gingival colour and gingival shape. The scoring system was a five point 
scale: 1 – much worse than before, 2 – slightly worse than before, 3 – no change, 4 – slight 
improvement and 5 – noticeable improvement. 
All patients appeared satisfied with the aesthetic results. According to the patient 
questionnaire, most sites (both control and test sites) either improved or remained 
unchanged. Patient E was the exception. She scored the gingival level at all three control 
sites as “slightly worse than before” and the corresponding test sites as “slightly improved”. 
Her perception is mirrored in the clinical results where statistical analysis showed that the 
control group worsened by 16% and the test group improved by 16.54%. With regards to 
aesthetic outcomes, she scored gingival colour and shape as unchanged at all sites.  Again, 
this is reflected in the PES. The PES for these sites showed either an improvement (control 
site E5) or it remained unchanged at a perfect score of 14. Analysis of patient E’s 
questionnaire supports the concept that patients can constructively contribute to 
determining the success or failure of clinical outcomes.    
On the other hand, patient F scored all control and test sites as 5 -“noticeable 
improvement”. The clinical results differed in that some of these sites worsened (i.e. control 
site F10 and test sites F10 and F11), three sites improved (control sites F8 and F11 and test 
site F8) and two sites remained unchanged (both control and test sites F9) over the study 
period. These incongruities between clinical results and the patient’s perceptions show a 
tendency of bias on the part of the patient.  He may be bias in wanting to favour a good 
result for me as an investigator. This shows that a patient’s perceptions can be skewed to 
the reality of outcomes. Similarly, patient B scored the gingival margin as “slightly 
improved” and gingival colour as “noticeable improvement” at the CTG site even though 
there was no change in the PES. Therefore, as a clinician, I may not deem this site an 
aesthetic success (due to the weak PES of 8 at the control site) but the patient seemed 
satisfied with the overall result. Again, the patient may be bias, wanting to favour good 
study results for me as an investigator. This concept is known as participant bias and is well 
documented in psychological studies. Participant bias occurs when participants want to 
make a useful contribution to the study and so will provide what they think is the “correct” 
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answers to provide the researcher with what he or she wants.134 In this study, patients B 
and F might have thought that the researchers wanted treatment outcomes to be excellent 
and therefore provided answers to this end. 
Despite this limitation, patients appeared satisfied with the aesthetic outcomes. There were 
no scores in the PRF group that worsened. Chambrone et al. consider aesthetics as the 
primary goal of root coverage procedures.132 Yet, very few studies consider aesthetic 
outcomes from a patient-based approach. In their systematic review of root coverage 
procedures, Chambrone et al. found only three RCTs that evaluated aesthetic outcomes 
according to patient opinions. Similar to the present study, Chambrone et al. also found that 
when patients were asked to evaluate aesthetic results, most patients were satisfied with 
the aesthetic outcome.132 Rotundo et al. set out to determine aesthetic perceptions after 
root coverage and interestingly found that clinicians can only expect patients to be fully 
satisfied with aesthetic results when complete root coverage is achieved.105 However, the 
present study found that patients can be satisfied with the aesthetic result even in the 
absence of complete root coverage.  
Another frequent goal of root coverage treatment is to reduce dentine sensitivity.132 As part 
of determining overall patient satisfaction, dentine sensitivity was one of the variables 
evaluated in the patient questionnaire. Dentine sensitivity is rarely reported on and yet it is 
one of the main factors that prompt patients to seek treatment.20  Of the twenty sites 
treated, fourteen sites were scored as improved (slight and noticeable improvement) with 
regards to dentine sensitivity. Six control sites and eight test sites were marked as improved. 
These results indicate that both CTGs and PRF can improve dentine sensitivity.  
Of all the patients treated, only patient C’s main concern was dentine sensitivity and she 
was very pleased with the result at the control site. In fact, she expressed interest to re-
treat the test site to improve sensitivity at this site. In patient C, recession measurements at 
the control site also showed greater reduction than the test site. There was almost 
complete resolution of the recession at the control site with improvements in KTW and GT. 
In patient C, these results suggest that CTG may provide better results with regards to 
dentine sensitivity than PRF. However, at this site, the PES decreased lowering the aesthetic 
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outcome but the patient was still happy with the result because her main complaint was 
addressed i.e. dentine hypersensitivity. This highlights that in addition to aesthetic 
outcomes, addressing a patient’s main complaint is also important in determining overall 
success or failure of treatment outcomes. 
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CHAPTER 7 
7 CONCLUSIONS 
To the best of my knowledge, this study is unique in the South African setting. Both CTGs 
and PRF demonstrated clinical and aesthetic improvements in gingival recession coverage. 
The results obtained for RD, CAL and GT were better in the CTG group whereas PRF 
demonstrated better results for RW and KTW. The aesthetic outcomes were the same for 
both groups. With regards to patient perceptions, PRF performed better than CTGs.  
The results from this study indicate that both CTGs and PRF membranes can be effective in 
treating gingival recession and both treatments can improve clinical and aesthetic 
outcomes.  
7.1 Limitations and recommendations 
 The small sample size 
Small sample sizes are a recurring limitation of most dental studies.135, 136 The ability to enrol 
a sufficient number of patients into a clinical study who meet the selection criteria can be a 
key limiting factor for obtaining a powerful study. Under-powered studies have a low 
probability of detecting true differences between treatments.135 This means that a study 
demonstrating results of ‘no difference’ between groups may, in fact, have too small a 
sample size to detect true differences between the groups and the overall estimate effect of 
the study is less precise. 
For future studies, a similarly designed RCT with a larger sample size and higher statistical 
power may provide a better understating of PRF efficacy. Hujoel et al. provide guidelines to 
increase a study’s power.135 They suggest that in addition to a rigid selection criteria for 
patient enrolment, the size of the lesions between groups and patients should be similar 
and in patients with multiple sites, the numbers of sites in each patient should be also be 
similar.135  
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 Method of measuring gingival recession depth 
In this study, small changes were noted in recession measurements over the study period. 
This study used a UNC-15 probe that is marked in 1mm increments. This type of measuring 
method was not able to detect smaller than 1mm changes in measurements. Perhaps a 
different method whereby smaller increments can be measured may provide a more 
accurate analysis of clinical outcomes. 3D digital measurements could help in this regard. 
 A relatively short study time 
Changes in soft tissue at treated sites were observed and recorded over a six month period. 
This is a relatively short observational time and studies have shown that there could be 
progressive coronal movement of the attached gingiva over a longer period of time.137 This 
phenomena has been termed creeping attachment and was first described in 1973 by 
Goldman and Cohen.138 They defined creeping attachment as “the post-operative migration 
of gingival marginal tissue in a coronal direction over portions of a previously denuded 
root.”138 The authors stated that this migration may be observed for extended periods after 
surgery until a constant marginal level is reached.138 This gingiva is usually firm, well 
attached with a healthy sulcus depth.139 Any improvement in recession measurements that 
occur after 4 weeks postoperatively is considered to be creeping attachment.137 In a study 
to determine the rate of creeping attachment, Bell et al. found that creeping attachment 
occurs at an average rate of 1mm over 12 months.140 In a retrospective study by Agudio et 
al. creeping attachment was observed at treated sites during the entire follow-up period (10 
to 25 years).141 However, creeping attachment is not predictable.137 Factors associated with 
increased creeping attachment are narrower recessions, younger patients, single tooth 
recession correction, tooth position and level of oral hygiene.137, 142  The studies by Lee et al. 
and Harris suggest that creeping attachment may occur commonly in areas where CTGs are 
placed.137, 143 Therefore, longer observational periods may produce different results.    
 Using photographs to evaluate aesthetics  
 Another limitation of the present study may be associated with the use of photographs to 
evaluate aesthetics as opposed to using direct clinical assessment of the patient. Clinical 
assessment would allow identification of the MGJ and this would allow using the RES (by 
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Cairo et al.104) as opposed to the PES which was used in this study. The RES was specifically 
designed to evaluate aesthetic outcomes of root coverage procedures.104 The RES uses MGJ 
alignment as one of its variables to evaluate aesthetic success. If aesthetics is evaluated 
clinically, the aesthetic score may be more representative of the outcomes of root coverage 
treatments.  
 Investigator bias when evaluating aesthetic outcomes 
The aesthetic evaluator was not blinded to the control and test sites. This could have 
created bias favouring one treatment over the other. Ensuring evaluator blindness can 
eliminate this bias. 
 Patient bias when answering the patient questionnaire 
Another limitation of this study was the method used to determine patient satisfaction. 
Patients were asked to complete a questionnaire based on a Likert-type scale. When 
analysing the results, it appeared that some patients may have been bias in their answers. 
This limitation has been recognised in psychological studies and is known as “participant 
bias”.  
Participant bias is when patients may consciously or unconsciously want to provide the 
researcher with what they perceive to be the desired outcome.134 A way to overcome this 
bias is to ensure complete anonymity with regards to every aspect of the questionnaire. All 
patients were familiar with the researchers as a relationship usually develops between 
doctor and patient. Therefore, a person not known to the patients should hand out and 
collect the questionnaire without any familiar persons around. Patients should also see that 
there would be no means for the researcher to identify their answers. Study participants 
might be influenced to answer questions more objectively if they are unfamiliar with the 
person in charge of the questionnaire.  
 Alternate way to determine patient-based outcomes  
In this study, patients were questioned on their aesthetic perception after treatment. In 
future studies, an additional patient questionnaire before treatment to assess their initial 
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perceptions of the aesthetic appearance of the oral tissues may be helpful to compare their 
perceptions on treatment outcomes. 
 Lack of histological evaluation  
This study has no histological component and is unable to determine the regenerative 
capacity of CTGs and PRF. Miller stated that although new connective tissue attachment is 
the ultimate goal of root coverage treatment, healing by long junctional epithelium is also 
acceptable.144 However, without histological data, the nature of any new gingival 
attachment is unknown. However, this is no different to other similar studies as ethical 
human research prevents this type of histological evaluation.
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CHAPTER 9 
9 APPENDICES 
9.1 Appendix 1: Patient Information Sheet and Consent Form 
 
Good day! 
 
This is an information document for patients invited to participate in a research project. 
 
The title of this research project is “Comparing clinical outcomes of connective tissue grafts to 
platelet rich fibrin in gingival recession treatment”.  
 
This form has two parts: 
1. Information Sheet (to share information about the research with you) 
2. Participant informed consent form (for signatures if you agree to take part) 
 
You will be given a copy of the full Informed Consent Form. 
 
 
PART 1: Information Sheet 
 
Introduction 
I, Dr. Fatima Peer, am conducting research on a new technique to treat gum recession. The results 
obtained in this study will contribute towards a Masters research report and is a requirement to my 
completing an MSc (Dent) degree. In this study, I want to compare a new type of tissue regrowth 
material; platelet rich fibrin to the common technique. You were selected as a possible participant in 
this study because you have the type of gum recession that is most likely to show good results after the 
operation.  
 
You are invited to participate in this study. Participation in this study is voluntary and no person will be 
advantaged or disadvantaged for choosing to participate or not participate in this study. The information 
sheet will provide you with the details of this study as well as what is required of the participant. You do 
not have to decide today whether or not you will participate in this study. Let me know within two (2) 
weeks of your decision. My contact number is 0116467560. Please ask me to stop as we go through 
the information and I will take time to explain.  If you have questions later, you can ask them of me.       
 
Purpose of the research 
Gum recession is a common problem that exposes a tooth’s root surface. The common technique uses 
tissue from the palate (roof of the mouth). Using this type of tissue has a risk of complications and can 
produce unfavourable aesthetic results. The new type of material that I want to test is platelet rich fibrin.  
Platelet rich fibrin is a substance found in blood that can stimulate bone and soft tissue (like gums) to 
regrow. This membrane is easily prepared from a small amount of your own blood and can eliminate 
the potential risks of grafting tissue from the palate. Its preparation is also simple and inexpensive and 
can reduce the costs of this type of oral surgery. It also has the potential to produce a more superior 
aesthetic result than the common technique. The purpose of this research is to find out if this new 
material is better than or at least equal to the common technique used to treat gum recession. 
 
What is involved in this research? 
If you volunteer to participate in this study, the study will first be explained to you. You will need to sign 
a consent form. You will then have to be available to have the surgery to treat your gum recession. You 
will need to have follow-up appointments to monitor healing. These appointments will be scheduled for 
2, 8, 12, 16 and 24 weeks after your surgery.  
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Before surgery, you will have a full dental examination and photographs of your mouth will be taken. I 
will ensure that your face will not be in any of the photographs and no-one will be able to identify you 
from the photographs. A cleaning will be done in preparation for the surgery. At the 24 week 
appointment, a full dental examination and photographs will be taken again to compare the before and 
after results. 
 
Procedures 
What is involved in the surgical procedure? 
Your gum recessions will be treated with 2 types of treatments. One side of your mouth will receive the 
common treatment (control) and the other side will receive the new material (test).  
 
I, Dr Fatima Peer, am the Researcher and will not be performing the operation. My supervisor, Dr 
Mohangi, will perform the operation. He is a specialist Periodontist and specialises in gum surgery. I 
will analyse and report on the data collected. 
 
The common treatment: 
Under local anaesthesia (your mouth will be numb), the surgical area will be prepared. A thin gum flap 
will be created and the root of the tooth being treated will be cleaned. A thin strip of gum will be taken 
from the roof of your mouth. You will be given a plastic to wear on your top jaw to protect the open 
wound during healing. The strip of gum will be placed at the base of the exposed tooth and covered 
with the gum flap and stitched together. 
 
The test procedure: 
Just before surgery, a small amount of your blood (2 teaspoons) will be collected from your arm using 
a syringe and needle. This blood will be used to make a thin membrane that will be used as the graft. 
Any leftover blood will be destroyed. 
As described above, under local anaesthesia, the surgical area will be prepared. A thin gum flap will be 
created and the root of the tooth being treated will be cleaned. The membrane that was made from your 
blood will be placed at the base of the exposed tooth and covered with the gum flap and stitched 
together.  
 
After surgery, there will be some pain in the recession area and in the roof of your mouth as it heals. 
The pain will be managed with pain killers and the plastic plate you will wear to protect the roof of your 
mouth will also help manage the pain in this area.  
Bleeding is a risk of surgery and can occur in the roof of your mouth. If this happens, continue wearing 
the plastic plate as this plate will apply pressure to stop the bleeding and contact me or Dr Mohangi 
immediately. Bleeding at the surgical area is less likely as stiches will protect the gum, but if bleeding 
does occur call me or Dr Mohangi and come to the Wits Dental School (during office hours) or to the 
outpatient (OPD) clinic at the Charlotte Maxeke Hospital (after hours). 
 
Our numbers are Dr Fatima Peer: 011 646 7560 / 079 527 4957 
                            Dr Mohangi 011 488 4886 / 083 777 1771 
 
After 2 weeks, I will ask you to return for your first follow-up appointment. At this appointment, I will 
assess healing and the stitches will be removed. I will give you oral hygiene instructions and show you 
how to keep the surgical area clean. You will be expected to maintain a high standard of oral hygiene 
through the length of the study. You will be expected to brush, floss and use a mouthwash. This is 
important to ensure the best possible results from the surgery. I will ask you to schedule appointments 
for 8, 12, 16 and 24 weeks. I will assess healing and remove any plaque in the area. . At the 24 week 
(6 month) appointment, I will carry out a full dental examination and take photographs again.  
 
After this appointment, I will ask you to complete a short questionnaire to determine your 
satisfaction/dissatisfaction with the aesthetic results. It will take approximately 10 minutes to complete 
the questionnaire. 
 
Participant selection 
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You are invited to participate in this study because the gum recession that you have is most likely to 
show good results after the operation. 
There will be 16 people taking part in this study. 
The procedures will be done at the Wits Dental School. A fee of R305 will be paid by the participant.  
There will be no financial compensation to anyone who chooses to take part in this study. 
 
 
Time needed for each appointment: 
 First appointment – 1 hour 
 Surgical appointment – 2 hours 
 2 week follow-up appointment – 30 minutes 
 8, 12, 16, week follow-up appointment -30 minutes 
 24 week  appointment – 1 hour 
 
Voluntary Participation 
Your participation in this research is entirely voluntary and refusal to participate will involve no penalty 
or loss of benefits. It is your choice whether to participate or not. You may change your mind later and 
withdraw from the study at any time without penalty or loss of benefits. You will not need to answer any 
questions should you not wish to. It is your choice and all of your rights will always be respected. 
 
Risks and complications 
Some patients do not respond successfully to gum surgery. Sometimes there is no change to the gum 
recession. 
 
There are some complications that may result from the surgery and/or any drugs used. These 
complications may include, but are not limited to, infection; bleeding; swelling; pain; temporary 
discoloration of the face; increase tooth looseness; tooth sensitivity to hot, cold, sweet or acidic foods; 
shrinkage of the new gum upon healing, resulting in elongation of some teeth and greater spaced 
between some teeth. Allergic reactions and accidental swallowing or inhaling of foreign matter are also 
possible. The duration of complications cannot be determined, and complications may be irreversible. 
Should any complications arise, they will be managed accordingly at the Wits Dental School. 
 
The success of gum surgery can be affected by medical conditions, dietary and nutritional problems, 
smoking, alcohol consumption, clenching and grinding of teeth, inadequate oral hygiene, and 
medications that you may be taking.  
 
Benefits 
The purpose of gum surgery is to create an amount of attached gum tissue that is wide enough to cover 
the exposed root surfaces, to improve aesthetics, to allow easier plaque removal, to reduce tooth 
sensitivity and pain, to prevent root decay and to prevent the possibility of further gum recession.  
 
Although there is no guarantee that treatment will be successful, in most cases the treatment should 
provide benefit in reducing the cause of your gum condition and should produce healing. 
 
 
Confidentiality 
Any information that is obtained in connection with this study and that can be identified with you will 
remain confidential. Absolute confidentiality cannot be guaranteed.   
 
I will not be sharing the identity of those participating in the research. The information that I collect from 
this research project will be kept confidential. Any information about you will have a number on it instead 
of your name keeping you anonymous. Information about you that will be collected during the research 
will be locked away in cabinet and no-one but the researchers will be able to see it. Organisations or 
persons that may inspect and/or copy my research records for quality assurance and data analysis 
include groups such as the Research Ethics Committee and my supervisors. 
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Sharing the Results 
All participants will be given important information on the study while involved in the project and after 
the results are available. The results will be available in a short (1page) summary to all participants 
approximately 6 months after the data has been collected. My research findings may be shared through 
publications. 
 
Who to Contact 
 
Researcher contact details: 
If you have any questions you may ask them now or later, even after the study has started. If you wish 
to ask questions later, you may contact me Dr. Fatima Peer on 011 646 7560 / 079 527 4957. 
 
You may also contact me or Dr Mohangi should you experience any complications after surgery and 
during the healing period. 
Dr Mohangi’s contact numbers are: 011 488 4886 / 083 777 1771 
 
Research ethics committee: 
If you have any complaints or problems that you wish to report, contact the Research Ethics Committee 
administrator, Professor Peter Cleaton-Jones on 011 717 2301. 
 
PART II: Patient informed consent form 
 
I have read the information above, or it has been read to me. I have had the opportunity to ask questions 
about it and any questions that I have asked have been answered to my satisfaction. I understand that 
there are risks associated with the procedure. I understand that I can withdraw from participating in this 
study at any point without penalty or loss of benefits. I consent voluntarily to participate as a participant 
in this study. 
 
 
Print Name of Participant __________________________________________________ 
 
 
Signature of Participant ____________________________________________________ 
 
 
Date _________________________________ 
 
 
Time ________________________________ 
     
  
 
 
 
Print Name of Researcher/person taking the consent_______________________________ 
    
Signature of Researcher /person taking the consent________________________________ 
 
 
Date ________________________________   
 
 
Time ________________________________ 
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9.2 Appendix 2: Case Report Form 
 
CASE REPORT FORM 
Protocol number: M150506 
Comparing clinical outcomes of connective tissue grafts to platelet rich fibrin 
in gingival recession treatment 
 
Participant number: _ _ _ 
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Participant number: _ _ _ 
 
Date of visit: ______________________ 
 
Demography: 
Sex:        M    /     F 
 
Date of birth: ________________ 
 
Vital signs: 
Sitting blood pressure: _______________   mmHg 
 
Sitting pulse: _______________________/ min 
 
 
 
 
 
 
 
 
Initial of Principal Investigator (PI) _________ 
Initial of Sub Investigator (SI) _________ 
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Participant number: _ _ _ 
Medical History: 
 
If yes, what medical conditions has the participant been diagnosed with? 
  Past Present 
 
Diagnosis   Controlled Active 
       
        
        
        
        
    
    
 
If yes, what allergies does the participant have? 
________________________________________________________________ 
Initial of PI _________ 
Initial of SI _________ 
  Yes No 
Does the participant have any significant 
medical history? 
    
  Yes No 
Does the participant have any allergies? 
    
 112 
 
 
Participant number: _ _ _ 
 
Inclusion Criteria:  
  YES NO 
·         2 contralateral/bilateral Miller’s class I or II lesions 
    
·         18 years old 
    
·         Good systemic health 
    
·         Good periodontal health *see periodontal chart 
    
·         Non-smoker 
    
·         PI ≤ 20 % 
    
 
Any ‘no’ response in the above section, disqualifies this participant from the 
study. 
 
 
 
 
 
 
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
 
Exclusion criteria: 
  YES NO 
·         Miller’s class III or IV recession lesions 
    
·         Pregnancy 
    
·         Bleeding disorders - uncontrolled 
    
·         Furcation involvement - related to maxillary 1st  
premolars 
    
·         Previous periodontal surgery - related to 
treatment of the recession lesions in the areas of 
interest 
    
 
Any ‘yes’ response in the above section, disqualifies this participant from the 
study. 
 
 
 
 
 
______________________________________________________________ 
We certify that this participant meets the study selection criteria to the best 
of our knowledge. 
Signature of PI: _____________________    Date of signature: ____________ 
Signature of SI: _____________________    Date of signature: ____________ 
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Participant number: _ _ _ 
 
 
 YES NO 
Informed consent 
    
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
Pre-surgical appointment  
Date: __________________________ 
 
Vital signs: 
Sitting blood pressure: _______________   mmHg 
Sitting pulse: _______________________/ min 
  
  
YES NO 
Review medical history 
  
Scale and polish 
    
Plaque control instructions 
    
Impressions  
    
Photographs 
    
 
 
 
 
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
Surgical appointment 
Date: ___________________________ 
 
Vital signs: 
Sitting blood pressure: _______________   mmHg 
Sitting pulse: _______________________/ min 
 
  YES No 
Review medical history  
    
 
Measure clinical parameters: 
  Control 
Site 
Test 
site YES NO 
·         Probing depth (mm) 
        
·         Recession depth (mm) 
        
·         Recession width (mm)      
        
·         Clinical attachment level (mm) 
        
·         Keratinised tissue width (mm) 
        
·         Gingival thickness (mm) 
        
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
 
  YES NO 
Randomisation     
Open envelope just before surgery     
 
 
Which quadrant is assigned to the control or test procedure? 
 
 Control Test 
1st quadrant     
2nd quadrant     
3rd quadrant     
4th quadrant     
 
 
 
 
 
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
Procedure 
  YES NO 
Control: 
    
·         Local anaesthetic : type 
    
·         Tunnel flap 
    
·         Root conditioning 
    
·         Palatal connective tissue graft 
    
·         Sutures 
    
Test: 
    
·         PRF preparation just before surgery 
    
·         Immediately centrifuged at 1500 rpm for 8 min 
    
·         PRF membrane created with metal box 
    
·         Local anaesthetic 
    
·         Tunnel flap 
    
·         Root conditioning 
    
·         PRF membrane placement 
    
·         Sutures 
    
Photographs during procedure 
  
 
Initial of PI _________                                                                              
 Initial of SI _________ 
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Participant number: _ _ _ 
Post-surgery protocol 
 YES NO 
·         Paracetamol 500mg -1g every 4-6 hours for 7 days 
    
·         Ibuprofen 200mg 3 X dly for 3 days 
    
·         0.2% chlorhexidine gluconate mouthwash;  15ml BD 
    
·         Instruct participant on  modified brushing technique 
for surgical area 
    
·       Set up 2 week recall appointment 
    
 
 
 
 
 
 
 
 
 
 
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
2 week recall appointment 
Date: __________________________ 
Vital signs: 
Sitting blood pressure: _______________   mmHg 
Sitting pulse: _______________________/ min 
 
 YES NO 
Review medical history 
  
·         Remove sutures 
    
·         Supragingival plaque removal 
    
·         Assess healing _______________________________ 
    
·         Oral hygiene motivation 
    
·         Photographs 
    
·     Set up 8 week (from date of surgery) recall 
appointment 
    
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
8 week recall appointment 
Date: ____________________________ 
Vital signs: 
Sitting blood pressure: _______________   mmHg 
Sitting pulse: _______________________/ min 
 
  YES No 
Review medical history  
    
 
Measure clinical parameters: 
  Control 
Site 
Test 
site YES NO 
·         Probing depth (mm) 
        
·         Recession depth (mm) 
        
·         Recession width (mm)      
        
·         Clinical attachment level (mm) 
        
·         Keratinised tissue width (mm) 
        
·         Gingival thickness (mm) 
        
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
 
 
YES NO 
Healing 
____________________________________________ 
    
Supragingival plaque removal 
    
Oral hygiene motivation 
    
Photographs 
    
Set up 12 week (from date of surgery) recall appointment 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
12 week recall appointment 
Date: ____________________________ 
Vital signs: 
Sitting blood pressure: _______________   mmHg 
Sitting pulse: _______________________/ min 
 
  YES No 
Review medical history  
    
 
Measure clinical parameters: 
  Control 
Site 
Test 
site YES NO 
·         Probing depth (mm) 
        
·         Recession depth (mm) 
        
·         Recession width (mm)      
        
·         Clinical attachment level (mm) 
        
·         Keratinised tissue width (mm) 
        
·         Gingival thickness (mm) 
        
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
 
 
YES NO 
Healing 
____________________________________________ 
    
Supragingival plaque removal 
    
Oral hygiene motivation 
    
Photographs 
    
Set up 16 week (from date of surgery) recall appointment 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
16 week recall appointment 
Date: ____________________________ 
Vital signs: 
Sitting blood pressure: _______________   mmHg 
Sitting pulse: _______________________/ min 
 
  YES No 
Review medical history  
    
 
Measure clinical parameters: 
  Control 
Site 
Test 
site YES NO 
·         Probing depth (mm) 
        
·         Recession depth (mm) 
        
·         Recession width (mm)      
        
·         Clinical attachment level (mm) 
        
·         Keratinised tissue width (mm) 
        
·         Gingival thickness (mm) 
        
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
 
 
YES NO 
Healing 
____________________________________________ 
    
Supragingival plaque removal 
    
Oral hygiene motivation 
    
Photographs 
    
Set up 24 week (from date of surgery) recall appointment 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
24 week recall appointment 
Date: ____________________________ 
Vital signs: 
Sitting blood pressure: _______________   mmHg 
Sitting pulse: _______________________/ min 
 
  YES No 
Review medical history  
    
 
Measure clinical parameters: 
  Control 
Site 
Test 
site YES NO 
·         Probing depth (mm) 
        
·         Recession depth (mm) 
        
·         Recession width (mm)      
        
·         Clinical attachment level (mm) 
        
·         Keratinised tissue width (mm) 
        
·         Gingival thickness (mm) 
        
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
 
 
YES NO 
Healing 
____________________________________________ 
    
Supragingival plaque removal 
    
Photographs 
    
Participant questionnaire 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial of PI _________ 
Initial of SI _________ 
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Participant number: _ _ _ 
Adverse event 
  YES NO 
Did the participant experience any adverse event during the study period?     
 
If ‘yes’ complete the table below 
Event Was event serious? Start date End date 
Related to the 
surgery Action taken Outcome 
1 
Yes* 
No 
  Yes* 
No  
 
2 
Yes* 
No 
  Yes* 
No 
  
3 
Yes* 
No 
  Yes* 
No 
  
*explain further 
Initial of PI _________ Initial of SI _________ 
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Participant number: _ _ _ 
Notes on adverse events 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
Initial of PI _________                                                                                      Initial of SI _________ 
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9.3 Appendix 3: Clinical Checklist 
 
  
Protocol activities to be 
completed 
Procedure appointment 
(Day) 
Recall appointments -  (weeks after 
procedure) 
  -14 -7 0 2 8 12 16 24 
Medical history X               
Vital signs: BP and Pulse X               
Periodontal examination X               
Inclusion and exclusion 
criteria   X             
Informed consent   X             
Randomisation    X X           
Scale and Polish   X             
Plaque control Instructions   X             
Impressions   X             
Photographs   X X X X X X X 
Probing depth 
measurements     X   X X X X 
Recession depth 
measurements     X   X X X X 
Recession width 
measurements     X   X X X X 
Clinical attachment level 
measurements 
    X   X X X X 
Keratinised tissue width 
measurements 
    X   X X X X 
Gingival thickness 
measurements 
    X   X X X X 
Surgical procedures :                          
control and test     X           
Prescribing medication     X           
Setting up recall 
appointments     X X X X X   
Suture removal       X         
Supragingival plaque removal       X X X X X 
Healing assessment       X X X X X 
Oral hygiene motivation       X X X X X 
Participant questionnaire               X 
Adverse event        X X X X X 
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9.4 Appendix 4: Patient Questionnaire 
Participant Questionnaire 
Dear Participant 
This questionnaire will assess your satisfaction or dissatisfaction of the results of the surgery 
done to treat your gum recession. Kindly take a few minutes of your time to complete this 
form.  
 
Complete the table by rating your experience using the scale below: 
1 – Much worse than before 
2 – Slightly worse than before 
3 – No change 
4 – Slight improvement 
5 – Noticeable improvement 
  
 
Common treatment New treatment 
level of gum recession 
  
dentine sensitivity 
  
gum colour 
  
gum shape 
  
 
Are you satisfied with the overall aesthetic result? 
________________________________________________________________ 
________________________________________________________________ 
 
Do you have any further information you would like to share? 
________________________________________________________________ 
________________________________________________________________ 
Thank you again for your time and co-operation. 
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9.5 Appendix 5: Patient demographics and allocation of patient and pair numbers 
 
 
  
Patient Demographics 
Patient number  Pair Age Gender Tooth 
 Control 
(C) or Test 
(T) 
A A1 69 M 13 C 
        23 T 
B B2 66 M 23 C 
      13 T 
C C3 29 F 14 C 
        24 T 
D D4 40 F 35 C 
      45 T 
E E5  41 F 14 C 
        24 T 
E E6 41  F 45 C 
     35 T 
E E7  41 F 44 C 
        34 T 
F F8 47 M 15 C 
      45 T 
F F9 47 M 14 C 
        24 T 
F F10 47 M 13 C 
      23 T 
F F11 47 M 34 C 
        44 T 
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9.6 Appendix 6: Ethical Clearance Certificate. 
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9.7 Appendix 7: Good Clinical Practise certificates. 
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9.8 Appendix 8: Tabulation of PD measurements. 
 
  
MB B DB Ave MB B DB Ave MB B DB Ave MB B DB Ave MB B DB Ave
C 2 2 2 2,00 3 3 3 3,00 2 2 2 2,00 3 2 3 2,67 2 2 2 2,00
T 2 2 2 2,00 3 3 2 2,67 2 2 2 2,00 2 1 1 1,33 2 2 2 2,00
C 3 2 1 2,00 4 4 3 3,67 3 1 2 2,00 3 1 3 2,33 2 2 2 2,00
T 3 3 4 3,33 2 2 1 1,67 2 2 2 2,00 2 3 2 2,33 3 3 3 3,00
C 2 2 2 2,00 1 1 1 1,00 2 2 2 2,00 2 2 2 2,00 2 2 2 2,00
T 2 2 2 2,00 2 2 1 1,67 3 2 1 2,00 3 3 2 2,67 3 2 2 2,33
C 1 1 1 1,00 1 1 2 1,33
T 1 1 2 1,33 2 1 2 1,67
C 2 2 2 2,00 2 2 2 2,00 2 2 2 2,00 2 2 1 1,67 2 2 2 2,00
T 2 1 2 1,67 2 2 2 2,00 3 2 3 2,67 3 1 2 2,00 2 2 2 2,00
C 2 2 2 2,00 2 2 3 2,33 1 1 2 1,33 2 2 3 2,33 2 2 3 2,33
T 2 2 3 2,33 3 2 3 2,67 2 3 2 2,33 2 1 2 1,67 2 2 2 2,00
C 3 1 3 2,33 3 1 2 2,00 1 1 2 1,33 2 1 2 1,67 2 1 2 1,67
T 2 2 2 2,00 1 2 1 1,33 1 1 2 1,33 1 1 1 1,00 2 2 2 2,00
C 2 2 2 2,00 2 1 1 1,33 2 1 1 1,33 2 1 2 1,67 2 2 2 2,00
T 1 2 2 1,67 3 1 2 2,00 3 2 2 2,33 3 2 2 2,33 2 2 3 2,33
C 2 1 2 1,67 2 2 2 2,00 2 2 2 2,00 2 2 2 2,00 2 2 2 2,00
T 2 2 1 1,67 2 1 2 1,67 2 1 1 1,33 2 1 2 1,67 3 1 2 2,00
C 2 2 2 2,00 3 3 2 2,67 2 3 3 2,67 3 2 3 2,67 2 3 3 2,67
T 2 2 2 2,00 8 8 2 6,00 7 5 1 4,33 6 5 1 4,00 5 5 4 4,67
C 2 2 2 2,00 1 2 2 1,67 2 2 2 2,00 2 2 1 1,67 4 2 2 2,67
T 2 2 2 2,00 2 2 2 2,00 3 2 2 2,33 2 2 2 2,00 2 2 3 2,33
2,00 1,82 2,05 2,45 2,18 1,95 2,35 1,95 1,90 2,45 1,85 1,95 2,40 2,15 2,35
0,53 0,50 0,65 1,47 1,53 0,65 1,27 0,94 0,55 1,00 0,99 0,69 0,82 0,81 0,59
16 weeks 24 weeks
E5
E6
0 weeks 8 weeks 12 weeks
Pair
A1
B2
C3
D4 Patient did not comply with these recall appointments
Ave
St Dv
E7
F8
F9
F10
F11
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9.9 Appendix 9: Tabulation of RD measurements 
 
 
MB B DB Ave MB B DB Ave MB B DB Ave MB B DB Ave MB B DB Ave
C 4 4 3 3,67 3 2 2 2,33 3 3 1 2,33 2 2 2 2,00 2 3 2 2,33
T 3 3 2 2,67 4 4 2 3,33 3 2 1 2,00 3 3 1 2,33 3 3 1 2,33
C 3 3 2 2,67 1 2 2 1,67 0 1 2 1,00 0 1 2 1,00 1 2 1 1,33
T 3 4 2 3,00 0 1 1 0,67 1 1 0 0,66 0 1 0 0,33 0 2 2 1,33
C 0 1 1 0,67 1 1 1 1,00 0 0 0 0,00 0 1 1 0,67 0 1 0 0,33
T 0 1 1 0,67 0 1 1 0,67 0 0 1 0,33 0 0 1 0,33 0 1 1 0,67
C 1 3 1 1,67 0 1 0 0,33
T 1 2 1 1,33 1 2 1 1,33
C 1 2 1 1,33 1 2 2 1,67 1 2 2 1,67 0 1 1 0,67 2 1 1 1,33
T 1 1 1 1,00 1 1 1 1,00 0 1 1 0,67 0 1 1 0,67 0 1 1 0,67
C 1 2 1 1,33 0 1 1 0,67 1 2 1 1,33 3 2 2 2,33 3 2 2 2,33
T 2 2 1 1,67 1 2 0 1,00 0 2 0 0,66 2 2 0 1,33 1 2 1 1,33
C 0 3 1 1,33 0 2 2 1,33 1 2 1 1,33 1 2 2 1,67 0 2 1 1,00
T 1 2 1 1,33 0 2 1 1,00 1 2 1 1,33 0 2 1 1,00 1 2 1 1,33
C 2 2 1 1,67 2 2 1 1,67 2 2 2 2,00 2 3 1 2,00 1 2 1 1,33
T 1 3 1 1,67 0 2 2 1,33 0 2 2 1,33 0 2 2 1,33 1 2 0 1,00
C 2 4 1 2,33 1 2 1 1,33 2 4 2 2,67 2 4 1 2,33 2 4 1 2,33
T 1 1 2 1,33 1 2 2 1,67 0 2 2 1,33 0 2 2 1,33 0 2 2 1,33
C 0 2 0 0,67 2 4 2 2,67 3 4 2 3,00 1 4 0 1 3 0 1,33
T 1 3 1 1,67 1 2 1 1,33 1 2 1 1,33 1 2 1 1,33 1 3 2 2,00
C 3 3 2 2,67 3 3 1 2,33 3 3 1 2,33 2 3 0 1,67 2 3 1 2,00
T 1 2 0 1,00 2 1 2 1,67 1 3 2 2,00 1 2 1 1,33 1 2 1 1,33
1,45 2,41 1,23 1,14 1,91 1,32 1,05 2,00 1,25 1,00 2,00 1,10 1,10 2,15 1,10
1,14 0,96 0,69 1,13 0,87 0,65 1,08 1,08 0,72 1,08 1,03 0,72 0,97 0,81 0,64
16 weeks 24 weeks
Patient
0 weeks 8 weeks 12 weeks
F11
A1
B2
C3
D4
E5
E6
E7
F8
F9
F10
Ave
St Dv
Patient did not comply with these recall appointments
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9.10  Appendix 10: Tabulation of RW measurements. 
 
 
  
0 weeks 8 weeks 12 weeks 16 weeks 24 weeks
C 7 6 6 6 6
T 7 7 6 7 6
C 5 5 4 4 4
T 5 3 4 4 4
C 3 4 0 3 0
T 4 4 4 2 3
C 4 3
T 5 4
C 4 4 4 3 4
T 3 3 3 3 3
C 3 3 4 3 3
T 4 4 3 3 4
C 3 4 4 3 3
T 4 4 4 4 3
C 5 5 5 4 5
T 4 4 5 3 5
C 5 4 5 5 5
T 5 4 5 4 5
C 4 5 5 6 5
T 6 6 6 6 6
C 5 5 5 5 5
T 4 5 4 4 4
4,50 4,36 4,30 4,10 4,15
1,14 1,05 1,34 1,33 1,42
Ave
St Dv
Patient did not comply with 
these recall appointments
E5
E6
Patient
A1
B2
C3
D4
E7
F8
F9
F10
F11
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9.11 Appendix 11: Tabulation of KTW measurements 
 
  
0 weeks 8 weeks 12 weeks 16 weeks 24 weeks
C 2 5 3 2 2
T 2 8 2 2 2
C 3 2 5 1 2
T 4 4 6 5 5
C 4 5 6 5 6
T 4 5 5 5 6
C 0,5 1
T 0,5 1
C 4 1 1 2 1
T 3 3 3 3 5
C 2 2 1 3 3
T 2 2 2 2 2
C 1 1 1 1 1
T 2 2 2 2 2
C 4 4 4 5 4
T 2 1 4 2 2
C 3 4 5 5 4
T 6 7 4 5 5
C 4 3 3 4 4
T 4 0 2 2 3
C 3 1 4 2 1
T 3 1 2 2 3
2,86 2,86 3,25 3,00 3,15
1,35 2,14 1,62 1,49 1,63
Pair
A1
B2
C3
D4 Patient did not comply with 
these recall appointments
Ave
St Dv
E7
F8
F9
F10
F11
E5
E6
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9.12 Appendix 12: Tabulation of GT measurements 
 
  
0 weeks 24 weeks
C 1,00 1,50
T 0,50 1,00
C 0,50 1,00
T 1,50 1,00
C 1,00 1,50
T 1,00 1,00
C 0,50
T 0,50
C 1,00 1,00
T 1,00 1,00
C 1,50 1,50
T 1,00 1,00
C 0,50 0,50
T 1,00 1,00
C 1,00 2,00
T 0,50 1,00
C 1,50 2,00
T 1,50 2,00
C 1,00 1,50
T 1,00 1,00
C 1,00 1,00
T 1,00 1,00
0,95 1,23
0,34 0,41
Pair
A1
B2
C3
D4 PDNC
Ave
St Dv
E7
F8
F9
F10
F11
E5
E6
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9.13  Appendix 13: Tabulation of CAL measurements. 
 
MB B DB Ave MB B DB Ave MB B DB Ave MB B DB Ave MB B DB Ave
C 6 6 5 5,67 6 5 5 5,33 5 5 3 4,33 5 4 5 4,67 4 5 4 4,33
T 5 5 4 4,67 7 7 5 6,33 5 4 3 4,00 5 4 2 3,67 5 5 3 4,33
C 6 5 3 4,67 5 6 5 5,33 3 2 4 3,00 3 2 5 3,33 3 4 3 3,33
T 6 7 6 6,33 2 3 2 2,33 3 3 2 2,67 2 4 2 2,67 3 5 5 4,33
C 2 3 3 2,67 2 2 2 2,00 2 2 2 2,00 2 3 3 2,67 2 3 2 2,33
T 2 3 3 2,67 2 3 2 2,33 3 2 2 2,33 3 3 3 3,00 3 3 3 3,00
C 2 4 2 2,67 1 2 2 1,67
T 2 3 3 2,67 3 3 3 3,00
C 3 4 3 3,33 3 4 4 3,67 3 4 4 3,67 2 3 2 2,33 4 3 3 3,33
T 3 2 3 2,67 3 3 3 3,00 3 3 4 3,33 3 2 3 2,67 2 3 3 2,67
C 3 4 3 3,33 2 3 4 3,00 2 3 3 2,67 5 4 5 4,67 5 4 5 4,67
T 4 4 3 3,67 4 4 3 3,67 2 5 2 3,00 4 3 2 3,00 3 4 3 3,33
C 3 4 4 3,67 3 3 4 3,33 2 3 3 2,67 3 3 4 3,33 2 3 3 2,67
T 3 4 3 3,33 1 4 2 2,33 2 3 3 2,67 2 3 2 2,33 3 4 3 3,33
C 4 4 3 3,67 4 3 2 3,00 4 3 3 3,33 4 4 3 3,67 3 4 3 3,33
T 2 5 3 3,33 3 3 4 3,33 3 4 4 3,67 3 4 4 3,67 3 4 3 3,33
C 4 5 3 4,00 3 4 3 3,33 4 6 4 4,67 4 6 3 4,33 4 6 3 4,33
T 3 3 3 3,00 3 3 4 3,33 2 3 3 2,67 2 3 4 3,00 3 3 4 3,33
C 2 4 2 2,67 5 7 4 5,33 5 7 5 5,67 4 6 3 4,33 3 6 3 4,00
T 3 5 3 3,67 9 10 3 7,33 8 7 2 5,67 7 7 2 5,33 6 8 6 6,67
C 5 5 4 4,67 4 5 3 4,00 5 5 3 4,33 4 5 1 3,33 6 5 3 4,67
T 3 4 2 3,00 4 3 4 3,67 4 5 4 4,33 3 4 3 3,33 3 4 4 3,67
3,45 4,23 3,23 3,59 4,09 3,32 3,50 3,95 3,15 3,50 3,85 3,05 3,50 4,30 3,45
1,37 1,11 0,92 1,92 1,93 1,04 1,54 1,54 0,88 1,32 1,31 1,15 1,19 1,30 0,94
Patient
E5
E6
E7
24 weeks
A1
B2
C3
D4
0 weeks 8 weeks 12 weeks 16 weeks
Patient did not comply with these recall appointments
Ave
St Dv
F8
F9
F10
F11
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9.14 Appendix 14: Tabulation of PES scores 
 
  
0 weeks 24 weeks
C 11 12
T 10 12
C 8 8
T 11 12
C 14 13
T 14 14
C 14
T 14
C 11 12
T 14 14
C 14 14
T 14 14
C 14 14
T 14 14
C 8 11
T 11 11
C 10 10
T 9 10
C 10 10
T 11 10
C 11 13
T 12 13
PDNC
F10
F11
Pair
A1
B2
C3
D4
E5
E6
E7
F8
F9
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9.15 Appendix 15: Tabulation of questionnaire answers 
Pair  
Q1 Level of gum 
recession- Control 
Q1 Level of gum 
recession- Test 
Q2 dentine 
sensitivity- Control 
Q2 dentine 
sensitivity- Test 
Q3 gum colour-
Control 
Q3 gum colour-Test 
Q4 gum shape-
Control 
Q4 gum shape-Test 
A1 No change No change Slight improvement Slight improvement No change No change No change No change 
B2 Slight improvement Slight improvement No change No change 
Noticeable 
improvement 
Noticeable 
improvement 
No change No change 
C3 No change No change 
Noticeable 
improvement 
No change No change No change No change No change 
D4 Did not complete the study 
E5 
Slightly worse than 
before 
Slight improvement 
Slightly worse than 
before 
Noticeable 
improvement 
No change No change No change No change 
E6 
Slightly worse than 
before 
Slight improvement 
Slightly worse than 
before 
Noticeable 
improvement 
No change No change No change No change 
E7 
Slightly worse than 
before 
Slight improvement 
Slightly worse than 
before 
Noticeable 
improvement 
No change No change No change No change 
.8 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
F9 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
F10 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
F11 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Noticeable 
improvement 
Count (N) 10 10 10 10 10 10 10 10 
Not answered 1 1 1 1 1 1 1 1 
Total 11 11 11 11 11 11 11 11 
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9.16 Appendix 16: Turnitin Report 
 
